{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioactive compounds", "natural compounds", "neuropsychiatric disorders", "pharmacological mechanisms", "preclinical pharmacology"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36188551", "DateRevised": {"Year": "2022", "Month": "10", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "15"}], "Language": ["eng"], "ELocationID": ["926607", "10.3389/fphar.2022.926607"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update.", "Pagination": {"StartPage": "926607", "MedlinePgn": "926607"}, "Abstract": {"AbstractText": ["Neuropsychiatric diseases are a group of disorders that cause significant morbidity and disability. The symptoms of psychiatric disorders include anxiety, depression, eating disorders, autism spectrum disorders (ASD), attention-deficit/hyperactivity disorder, and conduct disorder. Various medicinal plants are frequently used as therapeutics in traditional medicine in different parts of the world. Nowadays, using medicinal plants as an alternative medication has been considered due to their biological safety. Despite the wide range of medications, many patients are unable to tolerate the side effects and eventually lose their response. By considering the therapeutic advantages of medicinal plants in the case of side effects, patients may prefer to use them instead of chemical drugs. Today, the use of medicinal plants in traditional medicine is diverse and increasing, and these plants are a precious heritage for humanity. Investigation about traditional medicine continues, and several studies have indicated the basic pharmacology and clinical efficacy of herbal medicine. In this article, we discuss five of the most important and common psychiatric illnesses investigated in various studies along with conventional therapies and their pharmacological therapies. For this comprehensive review, data were obtained from electronic databases such as MedLine/PubMed, Science Direct, Web of Science, EMBASE, DynaMed Plus, ScienceDirect, and TRIP database. Preclinical pharmacology studies have confirmed that some bioactive compounds may have beneficial therapeutic effects in some common psychiatric disorders. The mechanisms of action of the analyzed biocompounds are presented in detail. The bioactive compounds analyzed in this review are promising phytochemicals for adjuvant and complementary drug candidates in the pharmacotherapy of neuropsychiatric diseases. Although comparative studies have been carefully reviewed in the preclinical pharmacology field, no clinical studies have been found to confirm the efficacy of herbal medicines compared to FDA-approved medicines for the treatment of mental disorders. Therefore, future clinical studies are needed to accelerate the potential use of natural compounds in the management of these diseases."], "CopyrightInformation": "Copyright \u00a9 2022 Asgharian, Quispe, Herrera-Bravo, Sabernavaei, Hosseini, Forouhandeh, Ebrahimi, Sharafi-Badr, Tarhriz, Soofiyani, Helon, Rajkovic, Durna Da\u015ftan, Docea, Sharifi-Rad, Calina, Koch and Cho."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Asgharian", "ForeName": "Parina", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Facultad de Ciencias de la Salud, Universidad Arturo Prat, Iquique, Chile."}], "LastName": "Quispe", "ForeName": "Cristina", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad Santo Tomas, Santo Tomas, Chile."}, {"Identifier": [], "Affiliation": "Center of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus, Universidad de La Frontera, Temuco, Chile."}], "LastName": "Herrera-Bravo", "ForeName": "Jes\u00fas", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Sabernavaei", "ForeName": "Mahsa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Department of Molecular Medicine, Faculty of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Hosseini", "ForeName": "Kamran", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious and Tropical Diseases Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Forouhandeh", "ForeName": "Haleh", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious and Tropical Diseases Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ebrahimi", "ForeName": "Tahereh", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Sharafi-Badr", "ForeName": "Paria", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious and Tropical Diseases Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Tarhriz", "ForeName": "Vahideh", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious and Tropical Diseases Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Clinical Research Development Unit of Sina Educational, Research and Treatment Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Soofiyani", "ForeName": "Saiedeh Razi", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Branch in Sandomierz, Jan Kochanowski University of Kielce, Sandomierz, Poland."}], "LastName": "Helon", "ForeName": "Pawe\u0142", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Faculty, Institute of Pharmacology, Clinical Pharmacology and Toxicology, University of Belgrade, Belgrade, Serbia."}], "LastName": "Rajkovic", "ForeName": "Jovana", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey."}, {"Identifier": [], "Affiliation": "Beekeeping Development Application and Research Center, Sivas Cumhuriyet University, Sivas, Turkey."}], "LastName": "Durna Da\u015ftan", "ForeName": "Sevgi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, University of Medicine and Pharmacy of Craiova, Craiova, Romania."}], "LastName": "Docea", "ForeName": "Anca Oana", "Initials": "AO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania."}], "LastName": "Calina", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food and Nutrition, Medical University of Lublin, Lublin, Poland."}], "LastName": "Koch", "ForeName": "Wojciech", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, China."}], "LastName": "Cho", "ForeName": "William C", "Initials": "WC"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbasi E., Nassiriasl M., Shafeei M., Sheikhi M. (2012). Neuroprotective effects of vitexin, a flavonoid, on pentylenetetrazole\u2010induced seizure in rats. Chem. Biol. Drug Des. 80, 274\u2013278. 10.1111/j.1747-0285.2012.01400.x", "ArticleIdList": ["10.1111/j.1747-0285.2012.01400.x", "22554436"]}, {"Citation": "Abdul Rahim N., Nordin N., Ahmad Rasedi N. I. S., Mohd Kauli F. S., Wan Ibrahim W. N., Zakaria F. (2022). Behavioral and cortisol analysis of the anti-stress effect of Polygonum minus (Huds) extracts in chronic unpredictable stress (CUS) zebrafish model. Comp. Biochem. Physiol. Part C: Toxicol. Pharmacol. 256, 109303. 10.1016/j.cbpc.2022.109303", "ArticleIdList": ["10.1016/j.cbpc.2022.109303", "35202824"]}, {"Citation": "Ajao A. A.-N., Alimi A. A., Olatunji O. A., Balogun F. O., Saheed S. A. (2018). A synopsis of anti-psychotic medicinal plants in Nigeria. Trans. R. Soc. S. Afr. 73, 33\u201341. 10.1080/0035919x.2017.1386138", "ArticleIdList": ["10.1080/0035919x.2017.1386138"]}, {"Citation": "Akhondzadeh S. (2007). \u201cHerbal medicines in the treatment of psychiatric and neurological disorders,\u201d in Low-cost approaches to promote physical and mental health (Springer; )."}, {"Citation": "Al-askar M., Bhat R. S., Selim M., AL-Ayadhi L., EL-Ansary A. (2017). Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism. BMC Complement. Altern. Med. 17, 259\u2013311. 10.1186/s12906-017-1763-7", "ArticleIdList": ["10.1186/s12906-017-1763-7", "PMC5424332", "28486989"]}, {"Citation": "Al-snafi A. E. (2015). The chemical constituents and pharmacological importance of Chrozophora tinctoria. Int J Pharm Rev Res 5, 391\u2013396."}, {"Citation": "Allen M. H., Hirschfeld R. M., Wozniak P. J., Baker P. D., Jeffrey D., Bowden C. L. (2006). Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am. J. Psychiatry 163, 272\u2013275. 10.1176/appi.ajp.163.2.272", "ArticleIdList": ["10.1176/appi.ajp.163.2.272", "16449481"]}, {"Citation": "Alshehri M. M., Quispe C., Herrera-Bravo J., Sharifi-Rad J., Tutuncu S., Aydar E. F., et al. (2022). A review of recent studies on the antioxidant and anti-infectious properties of Senna plants. Oxid. Med. Cell. Longev. 2022, 6025900. 10.1155/2022/6025900", "ArticleIdList": ["10.1155/2022/6025900", "PMC8837466", "35154569"]}, {"Citation": "Ameri A., Gleitz J., Peters T. (1996). Aconitine inhibits epileptiform activity in rat hippocampal slices. Naunyn. Schmiedeb. Arch. Pharmacol. 354, 80\u201385. 10.1007/BF00168710", "ArticleIdList": ["10.1007/BF00168710", "8832592"]}, {"Citation": "American Psychiatric Association A. (1980). Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association."}, {"Citation": "Anjaneyulu M., Chopra K., Kaur I. (2003). Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J. Med. Food 6, 391\u2013395. 10.1089/109662003772519976", "ArticleIdList": ["10.1089/109662003772519976", "14977450"]}, {"Citation": "Anlezark G., Meldrum B. (1978). Blockade of photically induced epilepsy by \u2018dopamine agonist\u2019ergot alkaloids. Psychopharmacology 57, 57\u201362. 10.1007/BF00426958", "ArticleIdList": ["10.1007/BF00426958", "96470"]}, {"Citation": "Arida R. M., Scorza F. A., Scorza C. A., Cavalheiro E. A. (2009). Is physical activity beneficial for recovery in temporal lobe epilepsy? Evidences from animal studies. Neurosci. Biobehav. Rev. 33, 422\u2013431. 10.1016/j.neubiorev.2008.11.002", "ArticleIdList": ["10.1016/j.neubiorev.2008.11.002", "19059282"]}, {"Citation": "Aseervatham G. S. B., Suryakala U., Sundaram S., Bose P. C., Sivasudha T. (2016). Expression pattern of NMDA receptors reveals antiepileptic potential of apigenin 8-C-glucoside and chlorogenic acid in pilocarpine induced epileptic mice. Biomed. Pharmacother. 82, 54\u201364. 10.1016/j.biopha.2016.04.066", "ArticleIdList": ["10.1016/j.biopha.2016.04.066", "27470339"]}, {"Citation": "Association A. P. (2006). American psychiatric association practice guidelines for the treatment of psychiatric disorders: Compendium 2006. American Psychiatric Pub."}, {"Citation": "Atkinson J. H., Slater M. A., Williams R. A., Zisook S., Patterson T. L., Grant I., et al. (1998). A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. pain 76, 287\u2013296. 10.1016/S0304-3959(98)00064-5", "ArticleIdList": ["10.1016/S0304-3959(98)00064-5", "9718247"]}, {"Citation": "Avallone R., Zanoli P., Puia G., Kleinschnitz M., Schreier P., Baraldi M. (2000). Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla . Biochem. Pharmacol. 59, 1387\u20131394. 10.1016/s0006-2952(00)00264-1", "ArticleIdList": ["10.1016/s0006-2952(00)00264-1", "10751547"]}, {"Citation": "Baek J. H., Nierenberg A. A., Kinrys G. (2014). Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder. Aust. N. Z. J. Psychiatry 48, 705\u2013715. 10.1177/0004867414539198", "ArticleIdList": ["10.1177/0004867414539198", "24947278"]}, {"Citation": "Banaschewski T., Roessner V., Dittmann R. W., Santosh P. J., Rothenberger A. (2004). Non\u2013stimulant medications in the treatment of ADHD. Eur. Child. Adolesc. Psychiatry 13, i102\u2013i116. 10.1007/s00787-004-1010-x", "ArticleIdList": ["10.1007/s00787-004-1010-x", "15322961"]}, {"Citation": "Banji D., Banji O. J., Abbagoni S., Hayath M. S., Kambam S., Chiluka V. L. (2011). Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Res. 1410, 141\u2013151. 10.1016/j.brainres.2011.06.063", "ArticleIdList": ["10.1016/j.brainres.2011.06.063", "21820650"]}, {"Citation": "Baureithel K. H., B\u00fcter K. B., Engesser A., Burkard W., Schaffner W. (1997). Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharm. Acta Helv. 72, 153\u2013157. 10.1016/s0031-6865(97)00002-2", "ArticleIdList": ["10.1016/s0031-6865(97)00002-2", "9204773"]}, {"Citation": "Begley C., Wagner R. G., Abraham A., Beghi E., Newton C., Kwon C. S., et al. (2022). The global cost of epilepsy: A systematic review and extrapolation. Epilepsia 63, 892\u2013903. 10.1111/epi.17165", "ArticleIdList": ["10.1111/epi.17165", "35195894"]}, {"Citation": "Berkov S., Osorio E., Viladomat F., Bastida J. (2020). Chemodiversity, chemotaxonomy and chemoecology of Amaryllidaceae alkaloids. Alkaloids. Chem. Biol. 83, 113\u2013185. 10.1016/bs.alkal.2019.10.002", "ArticleIdList": ["10.1016/bs.alkal.2019.10.002", "32098649"]}, {"Citation": "Berrettini W. (2003). \u201cEvidence for shared susceptibility in bipolar disorder and schizophrenia,\u201d in American journal of medical genetics Part C: Seminars in medical genetics (Wiley Online Library; ), 59\u201364.", "ArticleIdList": ["14601037"]}, {"Citation": "Bertolino B., Crupi R., Impellizzeri D., Bruschetta G., Cordaro M., Siracusa R., et al. (2017). Beneficial effects of co\u2010ultramicronized palmitoylethanolamide/luteolin in a mouse model of autism and in a case report of autism. CNS Neurosci. Ther. 23, 87\u201398. 10.1111/cns.12648", "ArticleIdList": ["10.1111/cns.12648", "PMC6492645", "27701827"]}, {"Citation": "Bhana N., Foster R. H., Olney R., Plosker G. L. (2001). Olanzapine: An updated review of its use in the management of schizophrenia. Olanzapine. Drugs 61, 111\u2013161. 10.2165/00003495-200161010-00011", "ArticleIdList": ["10.2165/00003495-200161010-00011", "11217867"]}, {"Citation": "Bhardwaj M., Kumar A. (2016). Neuroprotective effect of lycopene against PTZ\u2010induced kindling seizures in mice: Possible behavioural, biochemical and mitochondrial dysfunction. Phytother. Res. 30, 306\u2013313. 10.1002/ptr.5533", "ArticleIdList": ["10.1002/ptr.5533", "26633078"]}, {"Citation": "Bhutada P., Mundhada Y., Bansod K., Dixit P., Umathe S., Mundhada D. (2010). Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. Epilepsy Behav. 18, 207\u2013210. 10.1016/j.yebeh.2010.03.007", "ArticleIdList": ["10.1016/j.yebeh.2010.03.007", "20638957"]}, {"Citation": "Bidwell L. C., Mcclernon F. J., Kollins S. H. (2011). Cognitive enhancers for the treatment of ADHD. Pharmacol. Biochem. Behav. 99, 262\u2013274. 10.1016/j.pbb.2011.05.002", "ArticleIdList": ["10.1016/j.pbb.2011.05.002", "PMC3353150", "21596055"]}, {"Citation": "Birman H., \u00dcz\u00fcm G., Dar K. A., Kapucu A., Acar S. (2012). Effects of luteolin on liver, kidney and brain in pentylentetrazol-induced seizures: Involvement of metalloproteinases and NOS activities. Balk. Med. J. 29, 188\u2013196. 10.5152/balkanmedj.2011.030", "ArticleIdList": ["10.5152/balkanmedj.2011.030", "PMC4115855", "25206993"]}, {"Citation": "Blair H. A. (2020). Lumateperone: First approval. Drugs 80, 417\u2013423. 10.1007/s40265-020-01271-6", "ArticleIdList": ["10.1007/s40265-020-01271-6", "32060882"]}, {"Citation": "Brenner G. M., Stevens C. (2017). Brenner and stevens\u2019 pharmacology E-book. Elsevier Health Sciences."}, {"Citation": "Burris K. D., Molski T. F., Xu C., Ryan E., Tottori K., Kikuchi T., et al. (2002). Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther. 302, 381\u2013389. 10.1124/jpet.102.033175", "ArticleIdList": ["10.1124/jpet.102.033175", "12065741"]}, {"Citation": "Butnariu M., Quispe C., Herrera-Bravo J., Sharifi-Rad J., Singh L., Aborehab N. M., et al. (2022). The pharmacological activities of Crocus sativus L.: A review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid. Med. Cell. Longev. 2022, 8214821. 10.1155/2022/8214821", "ArticleIdList": ["10.1155/2022/8214821", "PMC8860555", "35198096"]}, {"Citation": "Butterweck V., J\u00fcrgenliemk G., Nahrstedt A., Winterhoff H. (2000). Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med. 66, 3\u20136. 10.1055/s-2000-11119", "ArticleIdList": ["10.1055/s-2000-11119", "10705724"]}, {"Citation": "Cai L., Li R., Tang W.-J., Meng G., Hu X.-Y., Wu T.-N. (2015). Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus\u2013pituitary\u2013adrenal axis. Eur. Neuropsychopharmacol. 25, 1332\u20131341. 10.1016/j.euroneuro.2015.04.009", "ArticleIdList": ["10.1016/j.euroneuro.2015.04.009", "25914157"]}, {"Citation": "Cannon J. R., Greenamyre J. T. (2011). The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol. Sci. 124, 225\u2013250. 10.1093/toxsci/kfr239", "ArticleIdList": ["10.1093/toxsci/kfr239", "PMC3216414", "21914720"]}, {"Citation": "Capra J. C., Cunha M. P., Machado D. G., Zomkowski A. D., Mendes B. G., Santos A. R., et al. (2010). Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (polygalaceae) in mice: Evidence for the involvement of monoaminergic systems. Eur. J. Pharmacol. 643, 232\u2013238. 10.1016/j.ejphar.2010.06.043", "ArticleIdList": ["10.1016/j.ejphar.2010.06.043", "20599906"]}, {"Citation": "Carlos filho B., Del Fabbro L., DE Gomes M. G., Goes A. T., Souza L. C., Boeira S. P., et al. (2013). Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test. Eur. J. Pharmacol. 698, 286\u2013291. 10.1016/j.ejphar.2012.11.003", "ArticleIdList": ["10.1016/j.ejphar.2012.11.003", "23178563"]}, {"Citation": "Chandler D. J., Waterhouse B. D., Gao W.-J. (2014). New perspectives on catecholaminergic regulation of executive circuits: Evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons. Front. Neural Circuits 8, 53. 10.3389/fncir.2014.00053", "ArticleIdList": ["10.3389/fncir.2014.00053", "PMC4033238", "24904299"]}, {"Citation": "Charney D. S., Manji H. K. (2004). Life stress, genes, and depression: Multiple pathways lead to increased risk and new opportunities for intervention. Sci. STKE, re5. 10.1126/stke.2252004re5", "ArticleIdList": ["10.1126/stke.2252004re5", "15039492"]}, {"Citation": "Charveron M., Assi\u00e9 M.-B., Stenger A., Briley M. (1984). Benzodiazepine agonist-type activity of raubasine, a rauwolfia serpentina alkaloid. Eur. J. Pharmacol. 106, 313\u2013317. 10.1016/0014-2999(84)90718-0", "ArticleIdList": ["10.1016/0014-2999(84)90718-0", "6099274"]}, {"Citation": "Chen H.-Q., Jin Z.-Y., Wang X.-J., Xu X.-M., Deng L., Zhao J.-W. (2008). Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci. Lett. 448, 175\u2013179. 10.1016/j.neulet.2008.10.046", "ArticleIdList": ["10.1016/j.neulet.2008.10.046", "18952146"]}, {"Citation": "Chen K., Kokate T. G., Donevan S. D., Carroll F. I., Rogawski M. A. (1996). Ibogaine block of the NMDA receptor: In vitro and in vivo studies. Neuropharmacology 35, 423\u2013431. 10.1016/0028-3908(96)84107-4", "ArticleIdList": ["10.1016/0028-3908(96)84107-4", "8793904"]}, {"Citation": "Chen X. D., Tang J. J., Feng S., Huang H., Lu F. N., Lu X. M., Wang Y. T. (2021). Chlorogenic acid improves PTSD-like symptoms and associated mechanisms. Curr. Neuropharmacol. 19 (12), 2180\u20132187. 10.2174/1570159X19666210111155110", "ArticleIdList": ["10.2174/1570159X19666210111155110", "PMC9185768", "33430733"]}, {"Citation": "Chengappa K. R., Bowie C. R., Schlicht P. J., Fleet D., Brar J. S., Jindal R. (2013). Randomized placebo-controlled adjunctive study of an extract of Withania somnifera for cognitive dysfunction in bipolar disorder. J. Clin. Psychiatry 74, 1076\u20131083. 10.4088/JCP.13m08413", "ArticleIdList": ["10.4088/JCP.13m08413", "24330893"]}, {"Citation": "Chiu S., Gericke N., Farina-Woodbury M., Badmaev V., Raheb H., Terpstra K., et al. (2014). Proof-of-concept randomized controlled study of cognition effects of the proprietary extract Sceletium tortuosum (zembrin) targeting phosphodiesterase-4 in cognitively healthy subjects: Implications for Alzheimer\u2019s dementia. Evidence-Based Complementary Altern. Med., 1\u20139. 10.1155/2014/682014", "ArticleIdList": ["10.1155/2014/682014", "PMC4217361", "25389443"]}, {"Citation": "Chiu S., Raheb H., Terpstra K., Vaughan J., Carrie A. (2017). Exploring standardized Zembrin\u00ae extracts from the South African plant Sceletium tortuosum in dual targeting phosphodiesterase-4 (PDE-4) and serotonin reuptake inhibition as potential treatment in schizophrenia. Int. J. Complement. Altern. Med. 6, 00203. 10.15406/ijcam.2017.06.00203", "ArticleIdList": ["10.15406/ijcam.2017.06.00203"]}, {"Citation": "Chung I.-W., Moore N. A., Oh W.-K., O'Neill M. F., Ahn J.-S., Park J.-B., et al. (2002). Behavioural pharmacology of polygalasaponins indicates potential antipsychotic efficacy. Pharmacol. Biochem. Behav. 71, 191\u2013195. 10.1016/s0091-3057(01)00648-7", "ArticleIdList": ["10.1016/s0091-3057(01)00648-7", "11812522"]}, {"Citation": "Clarke S. E. D., Ramsay R. R. (2011). Dietary inhibitors of monoamine oxidase A. J. Neural Transm. (Vienna). 118, 1031\u20131041. 10.1007/s00702-010-0537-x", "ArticleIdList": ["10.1007/s00702-010-0537-x", "21190052"]}, {"Citation": "Colovic M., Fracasso C., Caccia S. (2008). Brain-to-plasma distribution ratio of the biflavone amentoflavone in the mouse. Drug Metab. Lett. 2, 90\u201394. 10.2174/187231208784040988", "ArticleIdList": ["10.2174/187231208784040988", "19356077"]}, {"Citation": "Cooper J. O., Heron T. E., Heward W. L. (2007). Applied behavior analysis."}, {"Citation": "Cooper R. (2018). Diagnostic and statistical manual of mental disorders (DSM), 44. United Kingdom of Great Britain and Northern Ireland: KO KNOWLEDGE ORGANIZATION, 668\u2013676."}, {"Citation": "Cotterill T. (2019). Principles and practices of working with pupils with special educational needs and disability: A student guide. London: Routledge."}, {"Citation": "Cropley V., Croft R., Silber B., Neale C., Scholey A., Stough C., et al. (2012). Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharmacology 219, 737\u2013749. 10.1007/s00213-011-2395-0", "ArticleIdList": ["10.1007/s00213-011-2395-0", "21773723"]}, {"Citation": "Currier G. W., Trenton A. (2002). Pharmacological treatment of psychotic agitation. CNS drugs 16, 219\u2013228. 10.2165/00023210-200216040-00002", "ArticleIdList": ["10.2165/00023210-200216040-00002", "11945106"]}, {"Citation": "Da cruz G. M. P., Felipe C. F. B., Scorza F. A., Da Costa M. A. C., Tavares A. F., Menezes M. L. F., et al. (2013). Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms. Pharmacol. Biochem. Behav. 104, 144\u2013153. 10.1016/j.pbb.2013.01.002", "ArticleIdList": ["10.1016/j.pbb.2013.01.002", "23313550"]}, {"Citation": "Da silva A. F. S., DE Andrade J. P., Bevilaqua L. R., DE Souza M. M., Izquierdo I., Henriques A. T., et al. (2006). Anxiolytic-antidepressant-and anticonvulsant-like effects of the alkaloid montanine isolated from Hippeastrum vittatum . Pharmacol. Biochem. Behav. 85, 148\u2013154. 10.1016/j.pbb.2006.07.027", "ArticleIdList": ["10.1016/j.pbb.2006.07.027", "16950504"]}, {"Citation": "Dajas F., Rivera F., Blasina F., Arredondo F., Echeverry C., Lafon L., et al. (2003). Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox. Res. 5, 425\u2013432. 10.1007/BF03033172", "ArticleIdList": ["10.1007/BF03033172", "14715446"]}, {"Citation": "Darvesh A. S., Carroll R. T., Bishayee A., Novotny N. A., Geldenhuys W. J., VAN DER Schyf C. J. (2012). Curcumin and neurodegenerative diseases: A perspective. Expert Opin. Investig. Drugs 21, 1123\u20131140. 10.1517/13543784.2012.693479", "ArticleIdList": ["10.1517/13543784.2012.693479", "22668065"]}, {"Citation": "De deurwaerd\u00e8re P. (2016). Cariprazine: New dopamine biased agonist for neuropsychiatric disorders. Drugs Today 52, 97\u2013110. 10.1358/dot.2016.52.2.2461868", "ArticleIdList": ["10.1358/dot.2016.52.2.2461868", "27092339"]}, {"Citation": "De sousa D. P., Quintans L., JR, DE Almeida R. N. (2007). Evolution of the anticonvulsant activity of \u03b1-terpineol. Pharm. Biol. 45, 69\u201370. 10.1080/13880200601028388", "ArticleIdList": ["10.1080/13880200601028388"]}, {"Citation": "Deb S., Phukan B. C., Dutta A., Paul R., Bhattacharya P., Manivasagam T., et al. (2020). Natural products and their therapeutic effect on autism spectrum disorder. Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management, 601\u2013614.", "ArticleIdList": ["32006376"]}, {"Citation": "Derubeis R. J., Hollon S. D., Amsterdam J. D., Shelton R. C., Young P. R., Salomon R. M., et al. (2005). Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch. Gen. Psychiatry 62, 409\u2013416. 10.1001/archpsyc.62.4.409", "ArticleIdList": ["10.1001/archpsyc.62.4.409", "15809408"]}, {"Citation": "Di liberto V., M\u00e4kel\u00e4 J., Korhonen L., Olivieri M., Tselykh T., M\u00e4lki\u00e4 A., et al. (2012). Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice. Neuropharmacology 62, 1011\u20131018. 10.1016/j.neuropharm.2011.10.010", "ArticleIdList": ["10.1016/j.neuropharm.2011.10.010", "22041555"]}, {"Citation": "Dickerson F. B., Lehman A. F. (2011). Evidence-based psychotherapy for schizophrenia: 2011 update. J. Nerv. Ment. Dis. 199, 520\u2013526. 10.1097/NMD.0b013e318225ee78", "ArticleIdList": ["10.1097/NMD.0b013e318225ee78", "21814072"]}, {"Citation": "Dimpfel W. (2006). Different anticonvulsive effects of hesperidin and its aglycone hesperetin on electrical activity in the rat hippocampus in-vitro . J. Pharm. Pharmacol. 58, 375\u2013379. 10.1211/jpp.58.3.0012", "ArticleIdList": ["10.1211/jpp.58.3.0012", "16536905"]}, {"Citation": "Dipiro J. T., Talbert R. L., Yee G. C., Matzke G. R., Wells B. G., Posey L. M. (2014). Pharmacotherapy: A pathophysiologic approach. New York: McGraw-Hill Medical."}, {"Citation": "Dubowitz H., Prescott L., Feigelman S., Lane W., Kim J. (2008). Screening for intimate partner violence in a pediatric primary care clinic. Pediatrics 121, e85\u2013e91. 10.1542/peds.2007-0904", "ArticleIdList": ["10.1542/peds.2007-0904", "18166548"]}, {"Citation": "Edition F. (2013). Diagnostic and statistical manual of mental disorders, 21. American Psychiatric Association Publishing."}, {"Citation": "Enatescu V. R., Kalinovic R., Vlad G., Nussbaum L. A., Hogea L., Enatescu I., et al. (2020). The presence of peripheral inflammatory markers in patients with major depressive disorder, the associated symptoms profiles and the antidepressant efficacy of celecoxib. Farmacia 68, 483\u2013491. 10.31925/farmacia.2020.3.14", "ArticleIdList": ["10.31925/farmacia.2020.3.14"]}, {"Citation": "Evans S. W., Owens J. S., Wymbs B. T., Ray A. R. (2018). Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder. J. Clin. Child. Adolesc. Psychol. 47, 157\u2013198. 10.1080/15374416.2017.1390757", "ArticleIdList": ["10.1080/15374416.2017.1390757", "29257898"]}, {"Citation": "Fang K., Li H. R., Chen X. X., Gao X. R., Huang L. L., Du A. Q., Jiang C., Li H., Ge J. F. (2020). Quercetin alleviates LPS-induced depression-like behavior in rats via regulating BDNF-related imbalance of Copine 6 and TREM1/2 in the hippocampus and PFC. Front. Pharmacol. 10, 1544. 10.3389/fphar.2019.01544", "ArticleIdList": ["10.3389/fphar.2019.01544", "PMC6978986", "32009956"]}, {"Citation": "Fava M., Alpert J. E., Carmin C. N., Wisniewski S. R., Trivedi M. H., Biggs M. M., et al. (2004). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR* D. Psychol. Med. 34, 1299\u20131308. 10.1017/s0033291704002612", "ArticleIdList": ["10.1017/s0033291704002612", "15697056"]}, {"Citation": "Felipe F. C. B., Sousa Filho J. T., DE Oliveira Souza L. E., Silveira J. A., DE Andrade Uchoa D. E., Silveira E. R., et al. (2007). Piplartine, an amide alkaloid from Piper tuberculatum, presents anxiolytic and antidepressant effects in mice. Phytomedicine. 14, 605\u2013612. 10.1016/j.phymed.2006.12.015", "ArticleIdList": ["10.1016/j.phymed.2006.12.015", "17399971"]}, {"Citation": "Fern\u00e1ndez S. P., Wasowski C., Paladini A. C., Marder M. (2005). Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur. J. Pharmacol. 512, 189\u2013198. 10.1016/j.ejphar.2005.02.039", "ArticleIdList": ["10.1016/j.ejphar.2005.02.039", "15840404"]}, {"Citation": "Ferrari A. J., Baxter A. J., Whiteford H. A. (2011). A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J. Affect. Disord. 134, 1\u201313. 10.1016/j.jad.2010.11.007", "ArticleIdList": ["10.1016/j.jad.2010.11.007", "21131055"]}, {"Citation": "Fiest K. M., Sauro K. M., Wiebe S., Patten S. B., Kwon C.-S., Dykeman J., et al. (2017). Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology 88, 296\u2013303. 10.1212/WNL.0000000000003509", "ArticleIdList": ["10.1212/WNL.0000000000003509", "PMC5272794", "27986877"]}, {"Citation": "Fombonne E. (2009). Epidemiology of pervasive developmental disorders. Pediatr. Res. 65, 591\u2013598. 10.1203/PDR.0b013e31819e7203", "ArticleIdList": ["10.1203/PDR.0b013e31819e7203", "19218885"]}, {"Citation": "Fombonne E. (2006). Past and future perspectives on autism epidemiology."}, {"Citation": "Freedman R. (2010). The American psychiatric publishing textbook of psychopharmacology. American Psychiatric Association Publishing."}, {"Citation": "Fu M., Sun Z.-H., Zuo H.-C. (2010). Neuroprotective effect of piperine on primarily cultured hippocampal neurons. Biol. Pharm. Bull. 33, 598\u2013603. 10.1248/bpb.33.598", "ArticleIdList": ["10.1248/bpb.33.598", "20410592"]}, {"Citation": "Fujimaki K., Morinobu S., Duman R. S. (2000). Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacology 22, 42\u201351. 10.1016/S0893-133X(99)00084-6", "ArticleIdList": ["10.1016/S0893-133X(99)00084-6", "10633490"]}, {"Citation": "Galeotti N. (2017). Hypericum perforatum (St John\u2019s wort) beyond depression: A therapeutic perspective for pain conditions. J. Ethnopharmacol. 200, 136\u2013146. 10.1016/j.jep.2017.02.016", "ArticleIdList": ["10.1016/j.jep.2017.02.016", "28216196"]}, {"Citation": "Gawel K., Kukula-Koch W., Nieoczym D., Stepnik K., Ent V. W., Banono N. S., et al. (2020). The influence of palmatine isolated from Berberis sibirica Radix on pentylenetetrazole-induced seizures in zebrafish. Cells 9 (5), 1233. 10.3390/cells9051233", "ArticleIdList": ["10.3390/cells9051233", "PMC7290958", "32429356"]}, {"Citation": "Gawel K., Kukula-Koch W., Banono N. S., Nieoczym D., Targowska-Duda K. M., Czernicka L., Parada-Turska J., Esguerra C. V. (2021). 6-Gingerol, a major constituent of Zingiber officinale rhizoma, exerts anticonvulsant activity in the pentylenetetrazole-induced seizure model in larval zebrafish. Int. J. Mol. Sci. 22 (14), 7745. 10.3390/ijms22147745", "ArticleIdList": ["10.3390/ijms22147745", "PMC8305044", "34299361"]}, {"Citation": "Gericke N. P., Van wyk B.-E. (2001b). Pharmaceutical compositions containing mesembrine and related compounds. Google Patents."}, {"Citation": "Gericke N., Van wyk B. (2001a). African Natural Health CC. Pharmaceutical compositions containing mesembrine and related compounds."}, {"Citation": "Girish C., Raj V., Arya J., Balakrishnan S. (2012). Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur. J. Pharmacol. 682, 118\u2013125. 10.1016/j.ejphar.2012.02.034", "ArticleIdList": ["10.1016/j.ejphar.2012.02.034", "22387858"]}, {"Citation": "Goldberg D., Pilling S., Kendall T., Ferrier N., Foster T., Gates J., et al. (2005). Management of depression in primary and secondary care. London, England: Gaskell."}, {"Citation": "Golechha M., Chaudhry U., Bhatia J., Saluja D., Arya D. S. (2011). Naringin protects against kainic acid-induced status epilepticus in rats: Evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol. Pharm. Bull. 34, 360\u2013365. 10.1248/bpb.34.360", "ArticleIdList": ["10.1248/bpb.34.360", "21372385"]}, {"Citation": "Golechha M., Sarangal V., Bhatia J., Chaudhry U., Saluja D., Arya D. S. (2014). Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: Possible mechanisms of neuroprotection. Epilepsy Behav. 41, 98\u2013102. 10.1016/j.yebeh.2014.09.058", "ArticleIdList": ["10.1016/j.yebeh.2014.09.058", "25461197"]}, {"Citation": "Gopi S., Jacob J., Varma K., Jude S., Amalraj A., Arundhathy C., et al. (2017). Comparative oral absorption of curcumin in a natural turmeric matrix with two other curcumin formulations: An open\u2010label parallel\u2010arm study. Phytother. Res. 31, 1883\u20131891. 10.1002/ptr.5931", "ArticleIdList": ["10.1002/ptr.5931", "29027274"]}, {"Citation": "Guenne S., Balmus I., Hilou A., Ouattara N., Kiendreb\u00e9ogo M., Ciobica A., et al. (2016). The relevance of Asteraceae family plants in most of the neuropsychiatric disorders treatment. Int. J. Phyt 8, 176\u2013182."}, {"Citation": "Gullotta F., Schindler F., Schmutzler R., Weeks-Seifert A. (1985). GFAP in brain tumor diagnosis: Possibilities and limitations. Pathol. Res. Pract. 180, 54\u201360. 10.1016/S0344-0338(85)80075-3", "ArticleIdList": ["10.1016/S0344-0338(85)80075-3", "4034433"]}, {"Citation": "Gupta S., Black D. W., Smith D. A. (1994). Risperidone: Review of its pharmacology and therapeutic use in schizophrenia. Ann. Clin. Psychiatry. 6, 173\u2013180. 10.3109/10401239409149000", "ArticleIdList": ["10.3109/10401239409149000", "7533585"]}, {"Citation": "Gutmann H., Bruggisser R., Schaffner W., Bogman K., Botomino A., Drewe J. (2002). Transport of amentoflavone across the blood-brain barrier in vitro . Planta Med. 68, 804\u2013807. 10.1055/s-2002-34401", "ArticleIdList": ["10.1055/s-2002-34401", "12357391"]}, {"Citation": "Haleagrahara N., Radhakrishnan A., Lee N., Kumar P. (2009). Flavonoid quercetin protects against swimming stress-induced changes in oxidative biomarkers in the hypothalamus of rats. Eur. J. Pharmacol. 621, 46\u201352. 10.1016/j.ejphar.2009.08.030", "ArticleIdList": ["10.1016/j.ejphar.2009.08.030", "19744476"]}, {"Citation": "Han X. H., Hong S. S., Hwang J. S., Lee M. K., Hwang B. Y., Ro J. S. (2007). Monoamine oxidase inhibitory components from Cayratia japonica. Arch. Pharm. Res. 30, 13\u201317. 10.1007/BF02977772", "ArticleIdList": ["10.1007/BF02977772", "17328236"]}, {"Citation": "Hanks G. R. (2002). Narcissus and daffodil: The genus Narcissus. CRC Press."}, {"Citation": "Hasanzadeh E., Mohammadi M.-R., Ghanizadeh A., Rezazadeh S.-A., Tabrizi M., Rezaei F., et al. (2012). A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders. Child. Psychiatry Hum. Dev. 43, 674\u2013682. 10.1007/s10578-012-0292-3", "ArticleIdList": ["10.1007/s10578-012-0292-3", "22392415"]}, {"Citation": "Health N. C. C. F. M. (2009). Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults.", "ArticleIdList": ["22420012"]}, {"Citation": "Heinrich M., Appendino G., Efferth T., F\u00fcrst R., Izzo A. A., Kayser O., et al. (2020). Best practice in research \u2013 overcoming common challenges in phytopharmacological research. J. Ethnopharmacol. 246, 112230. 10.1016/j.jep.2019.112230", "ArticleIdList": ["10.1016/j.jep.2019.112230", "31526860"]}, {"Citation": "Heinrich M., Williamson E. M., Gibbons S., Barnes J., Prieto-Garcia J. (2017). Fundamentals of pharmacognosy and phytotherapy E-BOOK. Elsevier Health Sciences."}, {"Citation": "Hope J., Castle D., Keks N. A. (2018). Brexpiprazole: A new leaf on the partial dopamine agonist branch. Australas. Psychiatry. 26, 92\u201394. 10.1177/1039856217732473", "ArticleIdList": ["10.1177/1039856217732473", "29017334"]}, {"Citation": "Hossain R., Quispe C., Herrera-Bravo J., Beltr\u00e1n J. F., Islam M. T., Shaheen S., et al. (2022). Neurobiological promises of the bitter diterpene lactone andrographolide. Oxid. Med. Cell. Longev. 2022, 3079577. 10.1155/2022/3079577", "ArticleIdList": ["10.1155/2022/3079577", "PMC8825670", "35154564"]}, {"Citation": "Hossain R., Sarkar C., Hassan S. M. H., Khan R. A., Arman M., Ray P., et al. (2021). In silico screening of natural products as potential inhibitors of SARS-CoV-2 using molecular docking simulation. Chin. J. Integr. Med. 28, 249\u2013256. 10.1007/s11655-021-3504-5", "ArticleIdList": ["10.1007/s11655-021-3504-5", "PMC8672856", "34913151"]}, {"Citation": "Hosseinzadeh H., Noraei N. B. (2009). Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother. Res. 23, 768\u2013774. 10.1002/ptr.2597", "ArticleIdList": ["10.1002/ptr.2597", "19142981"]}, {"Citation": "Houslay M. D., Schafer P., Zhang K. Y. (2005). Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov. Today 10, 1503\u20131519. 10.1016/S1359-6446(05)03622-6", "ArticleIdList": ["10.1016/S1359-6446(05)03622-6", "16257373"]}, {"Citation": "Hsu C. D., Hsieh L. H., Chen Y. L., Lin I. C., Chen Y. R., Chen C. C., Shirakawa H., Yang S. C. (2021). Complementary effects of pine bark extract supplementation on inattention, impulsivity, and antioxidative status in children with attention-deficit hyperactivity disorder: A double-blinded randomized placebo-controlled cross-over study. Phytother. Res. 35 (6), 3226\u20133235. 10.1002/ptr.7036", "ArticleIdList": ["10.1002/ptr.7036", "33559134"]}, {"Citation": "Huang C.-W., Chow J. C., Tsai J.-J., Wu S.-N. (2012). Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability. Psychopharmacology 221, 575\u2013587. 10.1007/s00213-011-2603-y", "ArticleIdList": ["10.1007/s00213-011-2603-y", "22160139"]}, {"Citation": "Huen M. S., Leung J. W., Ng W., Lui W., Chan M. N., Wong J. T.-F., et al. (2003). 5, 7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties. Biochem. Pharmacol. 66, 125\u2013132. 10.1016/s0006-2952(03)00233-8", "ArticleIdList": ["10.1016/s0006-2952(03)00233-8", "12818372"]}, {"Citation": "Ishola I. O., Chatterjee M., Tota S., Tadigopulla N., Adeyemi O. O., Palit G., et al. (2012). Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice. Pharmacol. Biochem. Behav. 103, 322\u2013331. 10.1016/j.pbb.2012.08.017", "ArticleIdList": ["10.1016/j.pbb.2012.08.017", "22944105"]}, {"Citation": "Israelyan N., Margolis K. G. (2019). Reprint of: Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders. Pharmacol. Res. 140, 115\u2013120. 10.1016/j.phrs.2018.12.023", "ArticleIdList": ["10.1016/j.phrs.2018.12.023", "PMC6366671", "30658882"]}, {"Citation": "Jain A. (2020). Review article- bipolar disorder: Diagnosis, pathophysiology and therapy."}, {"Citation": "Jann M. W. (2014). Diagnosis and treatment of bipolar disorders in adults: A review of the evidence on pharmacologic treatments. Am. Health Drug Benefits 7, 489\u2013499.", "ArticleIdList": ["PMC4296286", "25610528"]}, {"Citation": "Jeong K. H., Jung U. J., Kim S. R. (2015). Naringin attenuates autophagic stress and neuroinflammation in kainic acid-treated hippocampus in vivo . Evidence-Based Complementary Altern. Med., 1\u20139. 10.1155/2015/354326", "ArticleIdList": ["10.1155/2015/354326", "PMC4466392", "26124853"]}, {"Citation": "Ji N. Y., Findling R. L. (2015). An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr. Opin. Psychiatry 28, 91\u2013101. 10.1097/YCO.0000000000000132", "ArticleIdList": ["10.1097/YCO.0000000000000132", "25602248"]}, {"Citation": "Jiang Z., Guo M., Shi C., Wang H., Yao L., Liu L., et al. (2015). Protection against cognitive impairment and modification of epileptogenesis with curcumin in a post-status epilepticus model of temporal lobe epilepsy. Neuroscience 310, 362\u2013371. 10.1016/j.neuroscience.2015.09.058", "ArticleIdList": ["10.1016/j.neuroscience.2015.09.058", "26415768"]}, {"Citation": "Johnson C. P., Myers S. M. American Academy of Pediatrics Council on Children With Disabilities (2007). Identification and evaluation of children with autism spectrum disorders. Pediatrics 120, 1183\u20131215. 10.1542/peds.2007-2361", "ArticleIdList": ["10.1542/peds.2007-2361", "17967920"]}, {"Citation": "Kanner A. M., Bicchi M. M. (2022). Antiseizure medications for adults with epilepsy: A review. Jama 327, 1269\u20131281. 10.1001/jama.2022.3880", "ArticleIdList": ["10.1001/jama.2022.3880", "35380580"]}, {"Citation": "Kaur R., Chopra K., Singh D. (2007). Role of alpha2 receptors in quercetin-induced behavioral despair in mice. J. Med. Food 10, 165\u2013168. 10.1089/jmf.2005.063", "ArticleIdList": ["10.1089/jmf.2005.063", "17472482"]}, {"Citation": "Kavvadias D., Sand P., Youdim K. A., Qaiser M. Z., Rice\u2010Evans C., Baur R., et al. (2004). The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood\u2013brain barrier and exhibits anticonvulsive effects. Br. J. Pharmacol. 142, 811\u2013820. 10.1038/sj.bjp.0705828", "ArticleIdList": ["10.1038/sj.bjp.0705828", "PMC1575061", "15231642"]}, {"Citation": "Kawabata K., Kawai Y., Terao J. (2010). Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary-adrenal axis response in Wistar rats. J. Nutr. Biochem. 21, 374\u2013380. 10.1016/j.jnutbio.2009.01.008", "ArticleIdList": ["10.1016/j.jnutbio.2009.01.008", "19423323"]}, {"Citation": "Kazmi I., Gupta G., Afzal M., Anwar F. (2012). Anticonvulsant and depressant-like activity of ursolic acid stearoyl glucoside isolated from Lantana camara L.(verbanaceae). Asian Pac. J. Trop. Dis. 2, S453\u2013S456. 10.1016/s2222-1808(12)60202-3", "ArticleIdList": ["10.1016/s2222-1808(12)60202-3"]}, {"Citation": "Kelvin E. A., Hesdorffer D. C., Bagiella E., Andrews H., Pedley T. A., Shih T. T., et al. (2007). Prevalence of self-reported epilepsy in a multiracial and multiethnic community in New York City. Epilepsy Res. 77, 141\u2013150. 10.1016/j.eplepsyres.2007.09.012", "ArticleIdList": ["10.1016/j.eplepsyres.2007.09.012", "18023147"]}, {"Citation": "Kessler R. C., Chiu W. T., Demler O., Walters E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62, 617\u2013627. 10.1001/archpsyc.62.6.617", "ArticleIdList": ["10.1001/archpsyc.62.6.617", "PMC2847357", "15939839"]}, {"Citation": "Kilpatrick J., Swafford J., Findell B., Council N. R. (2001). Adding it up: Helping children learn mathematics. Citeseer."}, {"Citation": "Komossa K., Depping A. M., Gaudchau A., Kissling W., Leucht S. (2010). Second\u2010generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst. Rev. 10.1002/14651858.cd008121.pub2", "ArticleIdList": ["10.1002/14651858.cd008121.pub2", "21154393"]}, {"Citation": "Kritas S., Saggini A., Varvara G., Murmura G., Caraffa A., Antinolfi P., et al. (2013). Luteolin inhibits mast cell-mediated allergic inflammation. J. Biol. Regul. Homeost. Agents 27, 955\u2013959.", "ArticleIdList": ["24382176"]}, {"Citation": "Kuhn B. N., Kalivas P. W., Bobadilla A.-C. (2019). Understanding addiction using animal models. Front. Behav. Neurosci. 13, 262. 10.3389/fnbeh.2019.00262", "ArticleIdList": ["10.3389/fnbeh.2019.00262", "PMC6895146", "31849622"]}, {"Citation": "Kulkarni S. K., Bhutani M. K., Bishnoi M. (2008). Antidepressant activity of curcumin: Involvement of serotonin and dopamine system. Psychopharmacology 201, 435\u2013442. 10.1007/s00213-008-1300-y", "ArticleIdList": ["10.1007/s00213-008-1300-y", "18766332"]}, {"Citation": "Kumar A., Lalitha S., Mishra J. (2014). Hesperidin potentiates the neuroprotective effects of diazepam and gabapentin against pentylenetetrazole-induced convulsions in mice: Possible behavioral, biochemical and mitochondrial alterations. Indian J. Pharmacol. 46, 309\u2013315. 10.4103/0253-7613.132180", "ArticleIdList": ["10.4103/0253-7613.132180", "PMC4071709", "24987179"]}, {"Citation": "Kumar A., Lalitha S., Mishra J. (2013). Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice. Epilepsy Behav. 29, 103\u2013111. 10.1016/j.yebeh.2013.06.007", "ArticleIdList": ["10.1016/j.yebeh.2013.06.007", "23939034"]}, {"Citation": "Kumaravel P., Melchias G., Vasanth N., Manivasagam T. (2017). Epigallocatechin gallate attenuates behavioral defects in sodium valproate induced autism rat model. Res. J. Pharm. Technol. 10, 1477\u20131480. 10.5958/0974-360x.2017.00260.8", "ArticleIdList": ["10.5958/0974-360x.2017.00260.8"]}, {"Citation": "Kunnumakkara A. B., Bordoloi D., Padmavathi G., Monisha J., Roy N. K., Prasad S., et al. (2017). Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br. J. Pharmacol. 174, 1325\u20131348. 10.1111/bph.13621", "ArticleIdList": ["10.1111/bph.13621", "PMC5429333", "27638428"]}, {"Citation": "Kwon C. S., Wagner R. G., Carpio A., Jett\u00e9 N., Newton C. R., Thurman D. J. (2022). The worldwide epilepsy treatment gap: A systematic review and recommendations for revised definitions - a report from the ilae epidemiology commission. Epilepsia 63, 551\u2013564. 10.1111/epi.17112", "ArticleIdList": ["10.1111/epi.17112", "35001365"]}, {"Citation": "Kwon S.-H., Lee H.-K., Kim J.-A., Hong S.-I., Kim H.-C., Jo T.-H., et al. (2010). Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol. 649, 210\u2013217. 10.1016/j.ejphar.2010.09.001", "ArticleIdList": ["10.1016/j.ejphar.2010.09.001", "20854806"]}, {"Citation": "Lake J. (2000). Natural product-derived treatments of neuropsychiatric disorders: Review of progress and recommendations. Stud. Nat. Prod. Chem. 24, 1093\u20131137."}, {"Citation": "Lam T. K., Shao S., Zhao Y., Marincola F., Pesatori A., Bertazzi P. A., et al. (2012). Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol. Biomarkers Prev. 21, 2176\u20132184. 10.1158/1055-9965.EPI-12-0745", "ArticleIdList": ["10.1158/1055-9965.EPI-12-0745", "PMC3538163", "23035181"]}, {"Citation": "Landa R. J. (2008). Diagnosis of autism spectrum disorders in the first 3 years of life. Nat. Clin. Pract. Neurol. 4, 138\u2013147. 10.1038/ncpneuro0731", "ArticleIdList": ["10.1038/ncpneuro0731", "18253102"]}, {"Citation": "Lane R., Baldwin D. (1997). Selective serotonin reuptake inhibitor-induced serotonin syndrome: Review. J. Clin. Psychopharmacol. 17, 208\u2013221. 10.1097/00004714-199706000-00012", "ArticleIdList": ["10.1097/00004714-199706000-00012", "9169967"]}, {"Citation": "Langguth B., B\u00e4r R., Wodarz N., Wittmann M., Laufk\u00f6tter R. (2011). Correspondence (letter to the editor): Paradoxical reaction in ADHD. Dtsch. Arztebl. Int. 108, 541. 10.3238/arztebl.2011.0541a", "ArticleIdList": ["10.3238/arztebl.2011.0541a", "PMC3163785", "21886668"]}, {"Citation": "Lavoie F. W., Gansert G. G., Weiss R. E. (1990). Value of initial ECG findings and plasma drug levels in cyclic antidepressant overdose. Ann. Emerg. Med. 19, 696\u2013700. 10.1016/s0196-0644(05)82482-5", "ArticleIdList": ["10.1016/s0196-0644(05)82482-5", "2188541"]}, {"Citation": "Lavretsky H. (2008). History of schizophrenia as a psychiatric disorder. Clin. Handb. schizophrenia 1."}, {"Citation": "Leskovec T. J., Rowles B. M., Findling R. L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harv. Rev. Psychiatry 16, 97\u2013112. 10.1080/10673220802075852", "ArticleIdList": ["10.1080/10673220802075852", "18415882"]}, {"Citation": "Levy S. E., Ds M. (2009). Autism. Lancet 374, 1627\u20131638. 10.1016/S0140-6736(09)61376-3", "ArticleIdList": ["10.1016/S0140-6736(09)61376-3", "PMC2863325", "19819542"]}, {"Citation": "Li Y.-C., Wang F.-M., Pan Y., Qiang L.-Q., Cheng G., Zhang W.-Y., et al. (2009). Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 435\u2013449. 10.1016/j.pnpbp.2009.01.006", "ArticleIdList": ["10.1016/j.pnpbp.2009.01.006", "19302828"]}, {"Citation": "Li R., Wang X., Qin T., Qu R., Ma S. (2016). Apigenin ameliorates chronic mild stress-induced depressive behavior by inhibiting interleukin-1\u03b2 production and NLRP3 inflammasome activation in the rat brain. Behav. Brain Res. 296, 318\u2013325. 10.1016/j.bbr.2015.09.031", "ArticleIdList": ["10.1016/j.bbr.2015.09.031", "26416673"]}, {"Citation": "Lim D. W., Han T., Jung J., Song Y., Um M. Y., Yoon M., et al. (2018). Chlorogenic Acid from Hawthorn berry (Crataegus pinnatifida fruit) prevents stress hormone\u2010induced depressive behavior, through monoamine oxidase b\u2010reactive oxygen species signaling in hippocampal astrocytes of mice. Mol. Nutr. Food Res. 62, 1800029. 10.1002/mnfr.201800029", "ArticleIdList": ["10.1002/mnfr.201800029", "29893510"]}, {"Citation": "Lin M.-T., Wang J.-J., Young M.-S. (2002). The protective effect of dl-tetrahydropalmatine against the development of amygdala kindling seizures in rats. Neurosci. Lett. 320, 113\u2013116. 10.1016/s0304-3940(01)02508-3", "ArticleIdList": ["10.1016/s0304-3940(01)02508-3", "11852175"]}, {"Citation": "Lin T.-Y., Lu C.-W., Wang C.-C., Lu J.-F., Wang S.-J. (2012). Hispidulin inhibits the release of glutamate in rat cerebrocortical nerve terminals. Toxicol. Appl. Pharmacol. 263, 233\u2013243. 10.1016/j.taap.2012.06.015", "ArticleIdList": ["10.1016/j.taap.2012.06.015", "22759588"]}, {"Citation": "Lin T. Y., Lu C. W., Wang C.-C., Wang Y.-C., Wang S.-J. (2011). Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: Possible relevance to its antidepressant mechanism. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1785\u20131793. 10.1016/j.pnpbp.2011.06.012", "ArticleIdList": ["10.1016/j.pnpbp.2011.06.012", "21741425"]}, {"Citation": "Liu Y.-F., Gao F., Li X.-W., Jia R.-H., Meng X.-D., Zhao R., et al. (2012). The anticonvulsant and neuroprotective effects of baicalin on pilocarpine-induced epileptic model in rats. Neurochem. Res. 37, 1670\u20131680. 10.1007/s11064-012-0771-8", "ArticleIdList": ["10.1007/s11064-012-0771-8", "22528832"]}, {"Citation": "London E. (2007). The role of the neurobiologist in redefining the diagnosis of autism. Brain Pathol. 17, 408\u2013411. 10.1111/j.1750-3639.2007.00103.x", "ArticleIdList": ["10.1111/j.1750-3639.2007.00103.x", "PMC8095627", "17919126"]}, {"Citation": "Lopez P. L., Torrente F. M., Ciapponi A., Lischinsky A. G., Cetkovich\u2010Bakmas M., Rojas J. I., et al. (2018). Cognitive\u2010behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst. Rev. 10.1002/14651858.cd010840.pub2", "ArticleIdList": ["10.1002/14651858.cd010840.pub2", "PMC6494390", "29566425"]}, {"Citation": "Luduvico K. P., Spohr L., Soares M. S. P., Teixeira F. C., DE Farias A. S., Bona N. P., et al. (2020). Antidepressant effect and modulation of the redox system mediated by tannic acid on lipopolysaccharide-induced depressive and inflammatory changes in mice. Neurochem. Res. 45, 2032\u20132043. 10.1007/s11064-020-03064-5", "ArticleIdList": ["10.1007/s11064-020-03064-5", "32500408"]}, {"Citation": "Kanazawa L. K. S., D\u00e9bora D. V., Eti\u00e9li W. M., Hocayen P. de A. S., dos Reis L\u00edvero F. A., Stipp M. C., et al. (2016). Quercetin reduces manic-like behavior and brain oxidative stress induced by paradoxical sleep deprivation in mice. Free Rad. Biol. Med. 99, 79\u201386. 10.1016/j.freeradbiomed.2016.07.027", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.07.027", "27475725"]}, {"Citation": "Kanazawa L. K., Vecchia D. D., Wendler E. M., Hocayen P. A., Beir\u00e3o P. S., de M\u00e9lo M. L., et al. (2017). Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress. Life Sci. 171, 1\u20138. 10.1016/j.lfs.2017.01.007", "ArticleIdList": ["10.1016/j.lfs.2017.01.007", "28104366"]}, {"Citation": "Kean J. D., Downey L. A., Sarris J., Kaufman J., Zangara A., Stough C. (2022). Effects of Bacopa monnieri (CDRI 08\u00ae) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial. Phytother. Res. 36 (2), 996\u20131012. 10.1002/ptr.7372", "ArticleIdList": ["10.1002/ptr.7372", "35041248"]}, {"Citation": "L\u00fcllmann H., Mohr K. (2006). Pharmakologie und Toxikologie: Arzneimittelwirkungen verstehen-Medikamente gezielt einsetzen; ein Lehrbuch f\u00fcr Studierende der Medizin, der Pharmazie und der Biowissenschaften, eine Informationsquelle f\u00fcr \u00c4rzte, Apotheker und Gesundheitspolitiker; 129 Tabellen. Georg Thieme Verlag."}, {"Citation": "Luszczki J. J., Andres-Mach M., Cisowski W., Mazol I., Glowniak K., Czuczwar S. J. (2009). Osthole suppresses seizures in the mouse maximal electroshock seizure model. Eur. J. Pharmacol. 607, 107\u2013109. 10.1016/j.ejphar.2009.02.022", "ArticleIdList": ["10.1016/j.ejphar.2009.02.022", "19236860"]}, {"Citation": "\u0141uszczki J. J., Andres-Mach M., Gle\u0144sk M., Skalicka-Wo\u017aniak K. (2010). Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: A comparative study. Pharmacol. Rep. 62, 1231\u20131236. 10.1016/s1734-1140(10)70387-x", "ArticleIdList": ["10.1016/s1734-1140(10)70387-x", "21273683"]}, {"Citation": "Lyon M. R., Cline J. C., DE Zepetnek J. T., Shan J. J., Pang P., Benishin C. (2001). Effect of the herbal extract combination panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: A pilot study. J. Psychiatry Neurosci. 26, 221\u2013228.", "ArticleIdList": ["PMC1408291", "11394191"]}, {"Citation": "Machado D. G., Bettio L. E., Cunha M. P., Santos A. R., Pizzolatti M. G., Brighente I. M., et al. (2008). Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. In mice: Evidence for the involvement of the serotonergic and noradrenergic systems. Eur. J. Pharmacol. 587, 163\u2013168. 10.1016/j.ejphar.2008.03.021", "ArticleIdList": ["10.1016/j.ejphar.2008.03.021", "18457827"]}, {"Citation": "Maiga A., Diallo D., Fane S., Sanogo R., Paulsen B. S., Cisse B. (2005). A survey of toxic plants on the market in the district of bamako, Mali: Traditional knowledge compared with a literature search of modern pharmacology and toxicology. J. Ethnopharmacol. 96, 183\u2013193. 10.1016/j.jep.2004.09.005", "ArticleIdList": ["10.1016/j.jep.2004.09.005", "15588669"]}, {"Citation": "Mitra S., Anjum J., Muni M., Das R., Rauf A., Islam F., et al. (2022). Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action. Biomed. Pharmacother. 149, 112877. 10.1016/j.biopha.2022.112877", "ArticleIdList": ["10.1016/j.biopha.2022.112877", "35367766"]}, {"Citation": "Malhi G., Adams D., Lampe L., Paton M., O\u2019Connor N., Newton L., et al. (2009). Clinical practice recommendations for bipolar disorder. Acta Psychiatr. Scand. 119, 27\u201346. 10.1111/j.1600-0447.2009.01383.x", "ArticleIdList": ["10.1111/j.1600-0447.2009.01383.x", "19356155"]}, {"Citation": "Mandah S. N., Osuagwu C. E. (2020). Characteristics behaviours and factors responsible for attention deficit hyperactivity disorder (ADHD) among senior secondary school students in rivers state, Nigeria. Eur. J. Special Educ. Res. 6."}, {"Citation": "Manji H. K., Drevets W. C., Charney D. S. (2001). The cellular neurobiology of depression. Nat. Med. 7, 541\u2013547. 10.1038/87865", "ArticleIdList": ["10.1038/87865", "11329053"]}, {"Citation": "Mann J. J., Currier D. (2006). Effects of genes and stress on the neurobiology of depression. Int. Rev. Neurobiol. 73, 153\u2013189. 10.1016/S0074-7742(06)73005-7", "ArticleIdList": ["10.1016/S0074-7742(06)73005-7", "16737904"]}, {"Citation": "Marder S. R., Meibach R. C. (1994). Risperidone in the treatment of schizophrenia. Am. J. Psychiatry 151, 825\u2013835. 10.1176/ajp.151.6.825", "ArticleIdList": ["10.1176/ajp.151.6.825", "7514366"]}, {"Citation": "Martens G., Van loo K. (2007). Genetic and environmental factors in complex neurodevelopmental disorders. Curr. Genomics 8, 429\u2013444. 10.2174/138920207783591717", "ArticleIdList": ["10.2174/138920207783591717", "PMC2647153", "19412416"]}, {"Citation": "Martin C. A., Nuzzo P. A., Ranseen J. D., Kleven M. S., Guenthner G., Williams Y., et al. (2018). Lobeline effects on cognitive performance in adult ADHD. J. Atten. Disord. 22, 1361\u20131366. 10.1177/1087054713497791", "ArticleIdList": ["10.1177/1087054713497791", "PMC4062608", "23966351"]}, {"Citation": "Martin-mcgill K. J., Bresnahan R., Levy R. G., Cooper P. N. (2020). Ketogenic diets for drug\u2010resistant epilepsy. Cochrane Database Syst. Rev. 10.1002/14651858.cd001903.pub5", "ArticleIdList": ["10.1002/14651858.cd001903.pub5", "PMC7387249", "32588435"]}, {"Citation": "Mcguffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. (2003). The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 60, 497\u2013502. 10.1001/archpsyc.60.5.497", "ArticleIdList": ["10.1001/archpsyc.60.5.497", "12742871"]}, {"Citation": "Medina J. H., Paladini A. C., Wolfman C., DE Stein M. L., Calvo D., Diaz L. E., et al. (1990). Chrysin (5, 7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem. Pharmacol. 40, 2227\u20132231. 10.1016/0006-2952(90)90716-x", "ArticleIdList": ["10.1016/0006-2952(90)90716-x", "2173925"]}, {"Citation": "Menza M., Dobkin R. D., Marin H., Mark M., Gara M., Buyske S., et al. (2009). A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72, 886\u2013892. 10.1212/01.wnl.0000336340.89821.b3", "ArticleIdList": ["10.1212/01.wnl.0000336340.89821.b3", "PMC2677475", "19092112"]}, {"Citation": "Miodownik C., Lerner V., Kudkaeva N., Lerner P. P., Pashinian A., Bersudsky Y., et al. (2019). Curcumin as add-on to antipsychotic treatment in patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled study. Clin. Neuropharmacol. 42 (4), 117\u2013122. 10.1097/WNF.0000000000000344", "ArticleIdList": ["10.1097/WNF.0000000000000344", "31045590"]}, {"Citation": "Miura T., Noma H., Furukawa T. A., Mitsuyasu H., Tanaka S., Stockton S., et al. (2014). Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: A systematic review and network meta-analysis. Lancet. Psychiatry 1, 351\u2013359. 10.1016/S2215-0366(14)70314-1", "ArticleIdList": ["10.1016/S2215-0366(14)70314-1", "26360999"]}, {"Citation": "Mo J., Guo Y., Yang Y.-S., Shen J.-S., Jin G.-Z., Zhen X. (2007). Recent developments in studies of l-stepholidine and its analogs: Chemistry, pharmacology and clinical implications. Curr. Med. Chem. 14, 2996\u20133002. 10.2174/092986707782794050", "ArticleIdList": ["10.2174/092986707782794050", "18220736"]}, {"Citation": "Mohr P., Pecenak J., Svestka J., Swingler D., Treuer T. (2005). Treatment of acute agitation in psychotic disorders. Neuro Endocrinol. Lett. 26, 327\u2013335.", "ArticleIdList": ["16136016"]}, {"Citation": "M\u00f6ller H.-J. (2005). Risperidone: A review. Expert Opin. Pharmacother. 6, 803\u2013818. 10.1517/14656566.6.5.803", "ArticleIdList": ["10.1517/14656566.6.5.803", "15934906"]}, {"Citation": "Mondiale de la sant\u00e9 A. (2013). Projet de plan d\u2019action pour la lutte contre les maladies non transmissibles 2013-2020: Rapport du Secr\u00e9tariat."}, {"Citation": "Moore A. R., O\u2019keeffe S. T. (1999). Drug-induced cognitive impairment in the elderly. Drugs Aging 15, 15\u201328. 10.2165/00002512-199915010-00002", "ArticleIdList": ["10.2165/00002512-199915010-00002", "10459729"]}, {"Citation": "Moreira A. L. R., VAN Meter A., Genzlinger J., Youngstrom E. A. (2017). Review and meta-analysis of epidemiologic studies of adult bipolar disorder. J. Clin. Psychiatry 78, e1259\u2013e1269. 10.4088/JCP.16r11165", "ArticleIdList": ["10.4088/JCP.16r11165", "29188905"]}, {"Citation": "Murray R. M., Sham P., VAN Os J., Zanelli J., Cannon M., Mcdonald C. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr. Res. 71, 405\u2013416. 10.1016/j.schres.2004.03.002", "ArticleIdList": ["10.1016/j.schres.2004.03.002", "15474912"]}, {"Citation": "Nakazawa T., Yasuda T., Ueda J., Ohsawa K. (2003). Antidepressant-like effects of apigenin and 2, 4, 5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol. Pharm. Bull. 26, 474\u2013480. 10.1248/bpb.26.474", "ArticleIdList": ["10.1248/bpb.26.474", "12673028"]}, {"Citation": "Napoletano M., Norcini G., Pellacini F., Marchini F., Morazzoni G., Ferlenga P., et al. (2001). Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1, 4-disubstituted derivatives. Bioorg. Med. Chem. Lett. 11, 33\u201337. 10.1016/s0960-894x(00)00587-4", "ArticleIdList": ["10.1016/s0960-894x(00)00587-4", "11140727"]}, {"Citation": "Nassiri-asl M., Shariati-Rad S., Zamansoltani F. (2008). Anticonvulsive effects of intracerebroventricular administration of rutin in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 989\u2013993. 10.1016/j.pnpbp.2008.01.011", "ArticleIdList": ["10.1016/j.pnpbp.2008.01.011", "18262708"]}, {"Citation": "Nestler E. J., Barrot M., Dileone R. J., Eisch A. J., Gold S. J., Monteggia L. M. (2002). Neurobiology of depression. Neuron 34, 13\u201325. 10.1016/s0896-6273(02)00653-0", "ArticleIdList": ["10.1016/s0896-6273(02)00653-0", "11931738"]}, {"Citation": "Nevitt S. J., Marson A. G., Smith C. T., Tudur Smith C. (2019). Carbamazepine versus phenytoin monotherapy for epilepsy: An individual participant data review. Cochrane Database Syst. Rev. 10.1002/14651858.cd001911.pub3", "ArticleIdList": ["10.1002/14651858.cd001911.pub3", "PMC6637502", "31318037"]}, {"Citation": "Nevitt S. J., Marson A. G., Weston J., Smith C. T. (2018). Sodium valproate versus phenytoin monotherapy for epilepsy: An individual participant data review. Cochrane Database Syst. Rev. 10.1002/14651858.cd001769.pub4", "ArticleIdList": ["10.1002/14651858.cd001769.pub4", "PMC6513104", "30091458"]}, {"Citation": "Newschaffer C. J., Croen L. A., Daniels J., Giarelli E., Grether J. K., Levy S. E., et al. (2007). The epidemiology of autism spectrum disorders. Annu. Rev. Public Health 28, 235\u2013258. 10.1146/annurev.publhealth.28.021406.144007", "ArticleIdList": ["10.1146/annurev.publhealth.28.021406.144007", "17367287"]}, {"Citation": "Newton C. R., Garcia H. H. (2012). Epilepsy in poor regions of the world. Lancet 380, 1193\u20131201. 10.1016/S0140-6736(12)61381-6", "ArticleIdList": ["10.1016/S0140-6736(12)61381-6", "23021288"]}, {"Citation": "Nogoceke F. P., Barcaro I. M. R., de Sousa D. P., Andreatini R. (2016). Antimanic-like effects of (R)-(\u2212)-carvone and (S)-(+)-carvone in mice. Neurosci. Lett. 619, 43\u201348. 10.1016/j.neulet.2016.03.013", "ArticleIdList": ["10.1016/j.neulet.2016.03.013", "26970377"]}, {"Citation": "Nourbala A., Akhoundzadeh S. 2006. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy."}, {"Citation": "Nussbaum L., Hogea L. M., Calina D., Andreescu N., Gradinaru R., Stefanescu R., et al. (2017). Modern treatment approaches in psychoses. PHARMACOGENETIC, neuroimagistic and clinical implications. Farmacia 65, 75\u201381."}, {"Citation": "Olsen H. T., Stafford G. I., VAN Staden J., Christensen S. B., J\u00e4ger A. K. (2008). Isolation of the MAO-inhibitor naringenin from Mentha aquatica L. J. Ethnopharmacol. 117, 500\u2013502. 10.1016/j.jep.2008.02.015", "ArticleIdList": ["10.1016/j.jep.2008.02.015", "18372132"]}, {"Citation": "\nWorld Health Organization (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Available at: https://apps.who.int/iris/handle/10665/37958\n."}, {"Citation": "Otte C., Gold S. M., Penninx B. W., Pariante C. M., Etkin A., Fava M., et al. (2016). Major depressive disorder. Nat. Rev. Dis. Prim. 2, 16065. 10.1038/nrdp.2016.65", "ArticleIdList": ["10.1038/nrdp.2016.65", "27629598"]}, {"Citation": "Pandy V., Vijeepallam K. (2017). Antipsychotic-like activity of scopoletin and rutin against the positive symptoms of schizophrenia in mouse models. Exp. Anim. 66 (4), 417\u2013423. 10.1538/expanim.17-0050", "ArticleIdList": ["10.1538/expanim.17-0050", "PMC5682354", "28701621"]}, {"Citation": "Painuli S., Quispe C., Herrera-Bravo J., Semwal P., Martorell M., Almarhoon Z. M., et al. (2022). Nutraceutical profiling, bioactive composition, and biological applications of Lepidium sativum L. Oxid. Med. Cell. Longev. 2022, 2910411. 10.1155/2022/2910411", "ArticleIdList": ["10.1155/2022/2910411", "PMC8791756", "35096265"]}, {"Citation": "Papakostas G. I. (2010). The efficacy, tolerability, and safety of contemporary antidepressants. J. Clin. Psychiatry 71, e03\u20130. 10.4088/JCP.9058se1c.03gry", "ArticleIdList": ["10.4088/JCP.9058se1c.03gry", "20371030"]}, {"Citation": "Park H. G., Yoon S. Y., Choi J. Y., Lee G. S., Choi J. H., Shin C. Y., et al. (2007). Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur. J. Pharmacol. 574, 112\u2013119. 10.1016/j.ejphar.2007.07.011", "ArticleIdList": ["10.1016/j.ejphar.2007.07.011", "17692312"]}, {"Citation": "Park H. R., Kong K. H., Yu B. P., Mattson M. P., Lee J. (2012). Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis. J. Biol. Chem. 287, 42588\u201342600. 10.1074/jbc.M112.406413", "ArticleIdList": ["10.1074/jbc.M112.406413", "PMC3522260", "23105098"]}, {"Citation": "Park S.-H., Sim Y.-B., Han P.-L., Lee J.-K., Suh H.-W. (2010). Antidepressant-like effect of chlorogenic acid isolated from Artemisia capillaris Thunb. Animal cells Syst. 14, 253\u2013259. 10.1080/19768354.2010.528192", "ArticleIdList": ["10.1080/19768354.2010.528192"]}, {"Citation": "Paul B. D., Snyder S. H. (2019). Therapeutic applications of cysteamine and cystamine in neurodegenerative and neuropsychiatric diseases. Front. Neurol. 10, 1315. 10.3389/fneur.2019.01315", "ArticleIdList": ["10.3389/fneur.2019.01315", "PMC6920251", "31920936"]}, {"Citation": "Paul S. M., Extein I., Calil H. M., Potter W. Z., Chodoff P., Goodwin F. K. (1981). Use of ECT with treatment-resistant depressed patients at the national institute of mental health. Am. J. Psychiatry 138, 486\u2013489. 10.1176/ajp.138.4.486", "ArticleIdList": ["10.1176/ajp.138.4.486", "6111228"]}, {"Citation": "\nPlantlist T. (2021). The plant List. Available: http://www.theplantlist.org/(Accessed, 2021). "}, {"Citation": "Pragnya B., Kameshwari J., Veeresh B. (2014). Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice. Behav. Brain Res. 270, 86\u201394. 10.1016/j.bbr.2014.04.045", "ArticleIdList": ["10.1016/j.bbr.2014.04.045", "24803211"]}, {"Citation": "Preskorn S. H., Simpson S. (1982). Tricyclic-antidepressant-induced delirium and plasma drug concentration. Am. J. Psychiatry 139, 822\u2013823. 10.1176/ajp.139.6.822", "ArticleIdList": ["10.1176/ajp.139.6.822", "7081500"]}, {"Citation": "Prudic J., Haskett R. F., Mulsant B., Malone K. M., Pettinati H. M., Stephens S., et al. (1996). Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry 153, 985\u2013992. 10.1176/ajp.153.8.985", "ArticleIdList": ["10.1176/ajp.153.8.985", "8678194"]}, {"Citation": "Pyrzanowska J., Piechal A., Blecharz-Klin K., Joniec-Maciejak I., Zobel A., Widy-Tyszkiewicz E. (2012). Influence of long-term administration of rutin on spatial memory as well as the concentration of brain neurotransmitters in aged rats. Pharmacol. Rep. 64, 808\u2013816. 10.1016/s1734-1140(12)70876-9", "ArticleIdList": ["10.1016/s1734-1140(12)70876-9", "23087133"]}, {"Citation": "Qin T., Fang F., Song M., Li R., Ma Z., Ma S. (2017). Umbelliferone reverses depression-like behavior in chronic unpredictable mild stress-induced rats by attenuating neuronal apoptosis via regulating ROCK/Akt pathway. Behav. Brain Res. 317, 147\u2013156. 10.1016/j.bbr.2016.09.039", "ArticleIdList": ["10.1016/j.bbr.2016.09.039", "27646771"]}, {"Citation": "Quetglas-llabr\u00e9s M. M., Quispe C., Herrera-Bravo J., Catarino M. D., Pereira O. R., Cardoso S. M., et al. (2022). Pharmacological properties of bergapten: Mechanistic and therapeutic aspects. Oxid. Med. Cell. Longev. 2022, 8615242. 10.1155/2022/8615242", "ArticleIdList": ["10.1155/2022/8615242", "PMC9060977", "35509838"]}, {"Citation": "Quintans-j\u00fanior L. J., Guimar\u00e3es A. G., Ara\u00fajo B. E., Oliveira G. F., Santana M. T., Moreira F. V., et al. (2010). Carvacrol, (-)-borneol and citral reduce convulsant activity in rodents. Afr. J. Biotechnol. 9, 6566\u20136572."}, {"Citation": "Quispe C., Herrera-Bravo J., Javed Z., Khan K., Raza S., Gulsunoglu-Konuskan Z., et al. (2022). Therapeutic applications of curcumin in diabetes: A review and perspective. Biomed. Res. Int. 2022, 1375892. 10.1155/2022/1375892", "ArticleIdList": ["10.1155/2022/1375892", "PMC8828342", "35155670"]}, {"Citation": "Quitkin F. M., Liebowitz M. R., Stewart J. W., Mcgrath P. J., Harrison W., Rabkin J. G., et al. (1984). l-Deprenyl in atypical depressives. Arch. Gen. Psychiatry 41, 777\u2013781. 10.1001/archpsyc.1984.01790190051006", "ArticleIdList": ["10.1001/archpsyc.1984.01790190051006", "6430257"]}, {"Citation": "Quitkin F. M., Stewart J. W., Mcgrath P. J., Liebowitz M. R., Harrison W. M., Tricamo E., et al. (1988). Phenelzine versus imipramine in the treatment of probable atypical depression: Defining syndrome boundaries of selective MAOI responders. Am. J. Psychiatry 145, 306\u2013311. 10.1176/ajp.145.3.306", "ArticleIdList": ["10.1176/ajp.145.3.306", "3278631"]}, {"Citation": "Rajib H., Muhammad Torequl I., Pranta R., Divya J., Abu Saim Mohammad S., Lutfun N., et al. (2021). Amentoflavone, new hope against SARS-CoV-2: An outlook through its scientific records and an in silico study. Pharmacogn. Res. 13, 149\u2013157. 10.5530/pres.13.3.7", "ArticleIdList": ["10.5530/pres.13.3.7"]}, {"Citation": "Ramos-Hryb A. B., Cunha M. P., Kaster M. P., Rodrigues A. L. S. (2018). Natural polyphenols and terpenoids for depression treatment: Current status. Stud. Nat. Prod. Chem. 55, 181\u2013221. 10.1016/b978-0-444-64068-0.00006-1", "ArticleIdList": ["10.1016/b978-0-444-64068-0.00006-1"]}, {"Citation": "Rapin I., Tuchman R. F. (2008). Autism: Definition, neurobiology, screening, diagnosis. Pediatr. Clin. North Am. 55, 1129\u20131146. 10.1016/j.pcl.2008.07.005", "ArticleIdList": ["10.1016/j.pcl.2008.07.005", "18929056"]}, {"Citation": "Ravindran L. N., Stein M. B. (2010). The pharmacologic treatment of anxiety disorders: A review of progress. J. Clin. Psychiatry 71, 839\u2013854. 10.4088/jcp.10r06218blu", "ArticleIdList": ["10.4088/jcp.10r06218blu", "20667290"]}, {"Citation": "Raygude K. S., Kandhare A. D., Ghosh P., Bodhankar S. L. (2012). Anticonvulsant effect of fisetin by modulation of endogenous biomarkers. Biomed. Prev. Nutr. 2, 215\u2013222. 10.1016/j.bionut.2012.04.005", "ArticleIdList": ["10.1016/j.bionut.2012.04.005"]}, {"Citation": "Raza S. S., Khan M. M., Ahmad A., Ashafaq M., Khuwaja G., Tabassum R., et al. (2011). Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res. 1420, 93\u2013105. 10.1016/j.brainres.2011.08.047", "ArticleIdList": ["10.1016/j.brainres.2011.08.047", "21959178"]}, {"Citation": "Reaven J., Blakeley\u2010Smith A., Culhane\u2010Shelburne K., Hepburn S. (2012). Group cognitive behavior therapy for children with high\u2010functioning autism spectrum disorders and anxiety: A randomized trial. J. Child. Psychol. Psychiatry 53, 410\u2013419. 10.1111/j.1469-7610.2011.02486.x", "ArticleIdList": ["10.1111/j.1469-7610.2011.02486.x", "PMC4392045", "22435114"]}, {"Citation": "Reddy H. M., Poole J. S., Maguire G. A., Stahl S. M. (2020). New medications for neuropsychiatric disorders. Psychiatr. Clin. North Am. 43, 399\u2013413. 10.1016/j.psc.2020.02.008", "ArticleIdList": ["10.1016/j.psc.2020.02.008", "32439029"]}, {"Citation": "Recart V. M., Spohr L., Soares M. S. P., Mattos B. d. S., Bona N. P., Pedra N. S., et al. (2021). Gallic acid protects cerebral cortex, hippocampus, and striatum against oxidative damage and cholinergic dysfunction in an experimental model of manic-like behavior: Comparison with lithium effects. Int. J. Dev. Neurosci. 81, 167\u2013178. 10.1002/jdn.10086", "ArticleIdList": ["10.1002/jdn.10086", "33394512"]}, {"Citation": "Rossignol D. A., Frye R. E. (2014). Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front. Physiol. 5, 150. 10.3389/fphys.2014.00150", "ArticleIdList": ["10.3389/fphys.2014.00150", "PMC4001006", "24795645"]}, {"Citation": "Ryvlin P., Cross J. H., Rheims S. (2014). Epilepsy surgery in children and adults. Lancet. Neurol. 13, 1114\u20131126. 10.1016/S1474-4422(14)70156-5", "ArticleIdList": ["10.1016/S1474-4422(14)70156-5", "25316018"]}, {"Citation": "Sakurada T., Kuwahata H., Katsuyama S., Komatsu T., Morrone L. A., Corasaniti M. T., et al. (2009). Intraplantar injection of bergamot essential oil into the mouse hindpaw: Effects on capsaicin\u2010induced nociceptive behaviors. Int. Rev. Neurobiol. 85, 237\u2013248. 10.1016/S0074-7742(09)85018-6", "ArticleIdList": ["10.1016/S0074-7742(09)85018-6", "19607974"]}, {"Citation": "Salehi B., Calina D., Docea A. O., Koirala N., Aryal S., Lombardo D., et al. (2020). Curcumin's nanomedicine formulations for therapeutic application in neurological diseases. J. Clin. Med. 9, E430. 10.3390/jcm9020430", "ArticleIdList": ["10.3390/jcm9020430", "PMC7074182", "32033365"]}, {"Citation": "Salehi B., Imani R., Mohammadi M. R., Fallah J., Mohammadi M., Ghanizadeh A., et al. (2010). Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: A double blind, randomized controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 76\u201380. 10.1016/j.pnpbp.2009.09.026", "ArticleIdList": ["10.1016/j.pnpbp.2009.09.026", "19815048"]}, {"Citation": "Salehi B., Jornet P. L., Lopez E. P. F., Calina D., Sharifi-Rad M., Ramirez-Alarcon K., et al. (2019a). Plant-Derived bioactives in oral mucosal lesions: A key emphasis to curcumin, lycopene, chamomile, aloe vera, green tea and coffee properties. Biomolecules 9, E106. 10.3390/biom9030106", "ArticleIdList": ["10.3390/biom9030106", "PMC6468600", "30884918"]}, {"Citation": "Salehi B., Sestito S., Rapposelli S., Peron G., Calina D., Sharifi-Rad M., et al. (2019b). Epibatidine: A promising natural alkaloid in health. Biomolecules 9, 6. 10.3390/biom9010006", "ArticleIdList": ["10.3390/biom9010006", "PMC6359223", "30583611"]}, {"Citation": "Sarris J., Marx W., Ashton M. M., Ng C. H., Galvao-Coelho N., Ayati Z., et al. (2021). Plant-based medicines (phytoceuticals) in the treatment of psychiatric disorders: A meta-review of meta-analyses of randomized controlled trials: Les m\u00e9dicaments \u00e0 base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: Une m\u00e9ta-revue des m\u00e9ta-analyses d'essais randomis\u00e9s contr\u00f4l\u00e9s. Can. J. Psychiatry. 66, 849\u2013862. 10.1177/0706743720979917", "ArticleIdList": ["10.1177/0706743720979917", "PMC8573706", "33596697"]}, {"Citation": "Sasaki K., Iwata N., Ferdousi F., Isoda H. (2019). Antidepressant\u2010like effect of ferulic acid via promotion of energy metabolism activity. Mol. Nutr. Food Res. 63, 1900327. 10.1002/mnfr.201900327", "ArticleIdList": ["10.1002/mnfr.201900327", "PMC6790570", "31394019"]}, {"Citation": "Schimidt H. L., Garcia A., Martins A., Mello-Carpes P. B., Carpes F. P. (2017). Green tea supplementation produces better neuroprotective effects than red and black tea in Alzheimer-like rat model. Food Res. Int. 100, 442\u2013448. 10.1016/j.foodres.2017.07.026", "ArticleIdList": ["10.1016/j.foodres.2017.07.026", "28873707"]}, {"Citation": "Schmid C. L., Streicher J. M., Meltzer H. Y., Bohn L. M. (2014). Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a \u03b2arrestin2-independent activation of Akt. Neuropsychopharmacology 39, 1902\u20131913. 10.1038/npp.2014.38", "ArticleIdList": ["10.1038/npp.2014.38", "PMC4059899", "24531562"]}, {"Citation": "Schopler E., Reichler R. J., Renner B. R. (2010). The childhood autism rating scale (CARS). Los Angeles, CA, USA: WPS."}, {"Citation": "Seeger T. F., Seymour P., Schmidt A., Zorn S., Schulz D., Lebel L., et al. (1995). Ziprasidone (CP-88, 059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J. Pharmacol. Exp. Ther. 275, 101\u2013113.", "ArticleIdList": ["7562537"]}, {"Citation": "Shakeel S., Rehman M. U., Tabassum N., Amin U., Mir M. U. R. (2017). Effect of naringenin (a naturally occurring flavanone) against pilocarpine-induced status epilepticus and oxidative stress in mice. Pharmacogn. Mag. 13, S154\u2013S160. 10.4103/0973-1296.203977", "ArticleIdList": ["10.4103/0973-1296.203977", "PMC5407108", "28479741"]}, {"Citation": "Shao C., Yuan J., Liu Y., Qin Y., Wang X., Gu J., et al. (2020). Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis. Proc. Natl. Acad. Sci. U. S. A. 117, 10155\u201310164. 10.1073/pnas.1917946117", "ArticleIdList": ["10.1073/pnas.1917946117", "PMC7229752", "32327603"]}, {"Citation": "Shapiro D. A., Renock S., Arrington E., Chiodo L. A., Liu L.-X., Sibley D. R., et al. (2003). Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28, 1400\u20131411. 10.1038/sj.npp.1300203", "ArticleIdList": ["10.1038/sj.npp.1300203", "12784105"]}, {"Citation": "Sharifi-rad J., Quispe C., Herrera-Bravo J., Akram M., Abbaass W., Semwal P., et al. (2021a). Phytochemical constituents, biological activities, and health-promoting effects of the melissa officinalis. Oxidative Med. Cell. Longev. 2021, 1\u201320. 10.1155/2021/6584693", "ArticleIdList": ["10.1155/2021/6584693"]}, {"Citation": "Sharifi-rad J., Quispe C., Herrera-Bravo J., Martorell M., Sharopov F., Tumer T. B., et al. (2021b). A pharmacological perspective on plant-derived bioactive molecules for epilepsy. Neurochem. Res. 46, 2205\u20132225. 10.1007/s11064-021-03376-0", "ArticleIdList": ["10.1007/s11064-021-03376-0", "34120291"]}, {"Citation": "Sharifi-rad J., Quispe C., Herrera-Bravo J., Martorell M., Sharopov F., Tumer T. B., et al. (2021c). Pharmacological perspective on plant-derived bioactive molecules for epilepsy. Neurochem. Res. 46 (9), 2205\u20132225. 10.1007/s11064-021-03376-0", "ArticleIdList": ["10.1007/s11064-021-03376-0", "34120291"]}, {"Citation": "Sharifi-rad J., Quispe C., Kumar M., Akram M., Amin M., Iqbal M., et al. (2022). Hyssopus essential oil: An update of its phytochemistry, biological activities, and safety profile. Oxid. Med. Cell. Longev. 2022, 8442734. 10.1155/2022/8442734", "ArticleIdList": ["10.1155/2022/8442734", "PMC8776447", "35069979"]}, {"Citation": "Sharifi-rad J., Quispe C., Patra J. K., Singh Y. D., Panda M. K., Das G., et al. (2021d). Paclitaxel: Application in modern oncology and nanomedicine-based cancer therapy. Oxid. Med. Cell. Longev. 2021, 3687700. 10.1155/2021/3687700", "ArticleIdList": ["10.1155/2021/3687700", "PMC8545549", "34707776"]}, {"Citation": "Shyn S. I., Hamilton S. P. (2010). The genetics of major depression: Moving beyond the monoamine hypothesis. Psychiatr. Clin. North Am. 33, 125\u2013140. 10.1016/j.psc.2009.10.004", "ArticleIdList": ["10.1016/j.psc.2009.10.004", "PMC2824618", "20159343"]}, {"Citation": "Silva M. I. G., Silva M. A. G., DE Aquino Neto M. R., Moura B. A., DE Sousa H. L., DE Lavor E. P. H., et al. (2009). Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: Possible involvement of GABAergic system and antioxidant activity. Fitoterapia 80, 506\u2013513. 10.1016/j.fitote.2009.06.011", "ArticleIdList": ["10.1016/j.fitote.2009.06.011", "19559770"]}, {"Citation": "Silver J., Hales R., Yudolsky S. (1990). Psychiatric consultation to neurology. Rev. Psychiatry 9."}, {"Citation": "Silver J. M., Yudofsky S. C., Hales R. E. (1991). Depression in traumatic brain injury. Neuropsychiatry, Neuropsychology, Behav. Neurology."}, {"Citation": "Silver J. M., Yudofsky S. C., Hales R. E. (1994). Neuropsychiatry of traumatic brain injury. American Psychiatric Association."}, {"Citation": "Singh D., Goel R. K. (2016). Anticonvulsant mechanism of saponins fraction from adventitious roots of Ficus religiosa: Possible modulation of GABAergic, calcium and sodium channel functions. Rev. Bras. Farmacogn. 26, 579\u2013585. 10.1016/j.bjp.2015.10.007", "ArticleIdList": ["10.1016/j.bjp.2015.10.007"]}, {"Citation": "Singh I. (2008). Beyond polemics: Science and ethics of ADHD. Nat. Rev. Neurosci. 9, 957\u2013964. 10.1038/nrn2514", "ArticleIdList": ["10.1038/nrn2514", "19020513"]}, {"Citation": "Smith M. T., Crouch N. R., Gericke N., Hirst M. (1996). Psychoactive constituents of the genus Sceletium NE Br. And other mesembryanthemaceae: A review. J. Ethnopharmacol. 50, 119\u2013130. 10.1016/0378-8741(95)01342-3", "ArticleIdList": ["10.1016/0378-8741(95)01342-3", "8691846"]}, {"Citation": "Snyder S. H., Yamamura H. I. (1977). Antidepressants and the muscarinic acetylcholine receptor. Arch. Gen. Psychiatry 34, 236\u2013239. 10.1001/archpsyc.1977.01770140126014", "ArticleIdList": ["10.1001/archpsyc.1977.01770140126014", "14603"]}, {"Citation": "Soofiyani S. R., Hosseini K., Forouhandeh H., Ghasemnejad T., Tarhriz V., Asgharian P., et al. (2021). Quercetin as a novel therapeutic approach for lymphoma. Oxidative Med. Cell. Longev. 2021.", "ArticleIdList": ["PMC8352693", "34381559"]}, {"Citation": "Souza L. C., DE Gomes M. G., Goes A. T., Del Fabbro L., Carlos Filho B., Boeira S. P., et al. (2013). Evidence for the involvement of the serotonergic 5-HT1A receptors in the antidepressant-like effect caused by hesperidin in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 103\u2013109. 10.1016/j.pnpbp.2012.09.003", "ArticleIdList": ["10.1016/j.pnpbp.2012.09.003", "22996046"]}, {"Citation": "Spina E., De Domenico P., Ruello C., Longobardo N., Gitto C., Ancione M., Di Rosa A. E., Caputi A. P. (1994). Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients. Int. Clin. Psychopharmacol. 9 (4), 281\u2013286. 10.1097/00004850-199400940-00007", "ArticleIdList": ["10.1097/00004850-199400940-00007", "7868850"]}, {"Citation": "Spinella M. (2001). The psychopharmacology of herbal medicine: Plant drugs that alter mind, brain, and behavior. MIT Press."}, {"Citation": "Stahl S. M., Grady M. M., Moret C., Briley M. (2005). SNRIs: Their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr. 10, 732\u2013747. 10.1017/s1092852900019726", "ArticleIdList": ["10.1017/s1092852900019726", "16142213"]}, {"Citation": "Stahl S. M., Meyer J. M. (2020). The clozapine handbook. Cambridge University Press."}, {"Citation": "\nStansfield R. L. (2019). When attention deficit meets the \u201cAttention Economy\u201d. Dissertation thesis. Available at: https://unbscholar.lib.unb.ca/islandora/object/unbscholar%3A9820\n\n"}, {"Citation": "Steenkamp P., Harding N., VAN Heerden F., VAN Wyk B.-E. (2004). Fatal Datura poisoning: Identification of atropine and scopolamine by high performance liquid chromatography/photodiode array/mass spectrometry. Forensic Sci. Int. 145, 31\u201339. 10.1016/j.forsciint.2004.03.011", "ArticleIdList": ["10.1016/j.forsciint.2004.03.011", "15374592"]}, {"Citation": "Storeb\u00f8 O. J., Ramstad E., Krogh H. B., Nilausen T. D., Skoog M., Holmskov M., et al. (2015). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst. Rev. 2016. 10.1002/14651858.cd009885.pub2", "ArticleIdList": ["10.1002/14651858.cd009885.pub2", "PMC8763351", "26599576"]}, {"Citation": "Sundberg M., Sahin M. (2015). Cerebellar development and autism spectrum disorder in tuberous sclerosis complex. J. Child. Neurol. 30, 1954\u20131962. 10.1177/0883073815600870", "ArticleIdList": ["10.1177/0883073815600870", "PMC4644486", "26303409"]}, {"Citation": "Taheri Y., Quispe C., Herrera-Bravo J., Sharifi-Rad J., Ezzat S. M., Merghany R. M., et al. (2022). Urtica dioica-derived phytochemicals for pharmacological and therapeutic applications. Evid. Based. Complement. Altern. Med. 2022, 4024331. 10.1155/2022/4024331", "ArticleIdList": ["10.1155/2022/4024331", "PMC8894011", "35251206"]}, {"Citation": "Ta\u00efwe G. S., Kuete V. (2014). Neurotoxicity and neuroprotective effects of African medicinal plants. Toxicol. Surv. Afr. Med. plants, 423\u2013444. 10.1016/b978-0-12-800018-2.00014-5", "ArticleIdList": ["10.1016/b978-0-12-800018-2.00014-5"]}, {"Citation": "Takeda A., Sakamoto K., Tamano H., Fukura K., Inui N., Suh S. W., et al. (2011). Facilitated neurogenesis in the developing hippocampus after intake of theanine, an amino acid in tea leaves, and object recognition memory. Cell. Mol. Neurobiol. 31, 1079\u20131088. 10.1007/s10571-011-9707-0", "ArticleIdList": ["10.1007/s10571-011-9707-0", "21604187"]}, {"Citation": "Taviano M., Miceli N., Monforte M., Tzakou O., Galati E. (2007). Ursolic acid plays a role in Nepeta sibthorpii Bentham CNS depressing effects. Phytother. Res. 21, 382\u2013385. 10.1002/ptr.2076", "ArticleIdList": ["10.1002/ptr.2076", "17236171"]}, {"Citation": "Taylor G., Mcneill A., Girling A., Farley A., Lindson-Hawley N., Aveyard P. (2014). Change in mental health after smoking cessation: Systematic review and meta-analysis. Bmj 348, g1151. 10.1136/bmj.g1151", "ArticleIdList": ["10.1136/bmj.g1151", "PMC3923980", "24524926"]}, {"Citation": "Theoharides T., Asadi S., Panagiotidou S. (2012). A case series of a luteolin formulation (NeuroProtek\u00ae) in children with autism spectrum disorders. London, England: SAGE Publications Sage UK.", "ArticleIdList": ["22697063"]}, {"Citation": "Tiihonen J., Mittendorfer-Rutz E., Majak M., Meht\u00e4l\u00e4 J., Hoti F., Jedenius E., et al. (2017). Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia. JAMA psychiatry 74, 686\u2013693. 10.1001/jamapsychiatry.2017.1322", "ArticleIdList": ["10.1001/jamapsychiatry.2017.1322", "PMC5710250", "28593216"]}, {"Citation": "Trebatick\u00e1 J., Kopasov\u00e1 S., Hrade\u010dn\u00e1 Z., \u010cinovsk\u00fd K., \u0160kod\u00e1\u010dek I., \u0160uba J., et al. . 2006. Treatment of ADHD with French maritime pine bark extract, Pycnogenol\u00ae. Eur. Child. Adolesc. Psychiatry, 15, 329\u2013335,. 10.1007/s00787-006-0538-3", "ArticleIdList": ["10.1007/s00787-006-0538-3", "16699814"]}, {"Citation": "Trofor L., Crisan-Dabija R., Cioroiu M. E., Man M. A., Cioroiu I. B., Buculei I., et al. (2020). Evaluation of oxidative stress in smoking and NON-smoking patients diagnosed with anxious-depressive disorder. Farmacia 68, 82\u201389. 10.31925/farmacia.2020.1.12", "ArticleIdList": ["10.31925/farmacia.2020.1.12"]}, {"Citation": "Tsilioni I., Taliou A., Francis K., Theoharides T. (2015). Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl. Psychiatry 5, e647. 10.1038/tp.2015.142", "ArticleIdList": ["10.1038/tp.2015.142", "PMC5545641", "26418275"]}, {"Citation": "Tsoukalas D., Buga A. M., Docea A. O., Sarandi E., Mitrut R., Renieri E., et al. (2021). Reversal of brain aging by targeting telomerase: A nutraceutical approach. Int. J. Mol. Med. 48, 199. 10.3892/ijmm.2021.5032", "ArticleIdList": ["10.3892/ijmm.2021.5032", "PMC8448543", "34515324"]}, {"Citation": "Tuchman R., Cuccaro M., Alessandri M. (2010). Autism and epilepsy: Historical perspective. Brain Dev. 32, 709\u2013718. 10.1016/j.braindev.2010.04.008", "ArticleIdList": ["10.1016/j.braindev.2010.04.008", "20510557"]}, {"Citation": "Uebel-von sandersleben H., Rothenberger A., Albrecht B., Rothenberger L. G., Klement S., Bock N. (2014). \u201cGinkgo biloba extract EGb 761\u00ae in children with ADHD,\u201d in Zeitschrift f\u00fcr Kinder-und Jugendpsychiatrie und Psychotherapie.", "ArticleIdList": ["25163996"]}, {"Citation": "Uk N. C. G. C. (2012). The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care.", "ArticleIdList": ["25340221"]}, {"Citation": "Underwood B. R., Imarisio S., Fleming A., Rose C., Krishna G., Heard P., et al. (2010). Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Hum. Mol. Genet. 19, 3413\u20133429. 10.1093/hmg/ddq253", "ArticleIdList": ["10.1093/hmg/ddq253", "PMC2916709", "20566712"]}, {"Citation": "Urdaneta K. E., Castillo M. A., Montiel N., Sempr\u00fan-Hern\u00e1ndez N., Antonucci N., Siniscalco D. (2018). Autism spectrum disorders: Potential neuro-psychopharmacotherapeutic plant-based drugs. Assay. Drug Dev. Technol. 16, 433\u2013444. 10.1089/adt.2018.848", "ArticleIdList": ["10.1089/adt.2018.848", "30427697"]}, {"Citation": "Van os J., Kapur S. (2009). Schizophrenia. Lancet 374, 635\u2013645. 10.1016/S0140-6736(09)60995-8", "ArticleIdList": ["10.1016/S0140-6736(09)60995-8", "19700006"]}, {"Citation": "Verrotti A., Tocco A., Salladini C., Latini G., Chiarelli F. (2005). Human photosensitivity: From pathophysiology to treatment. Eur. J. Neurol. 12, 828\u2013841. 10.1111/j.1468-1331.2005.01085.x", "ArticleIdList": ["10.1111/j.1468-1331.2005.01085.x", "16241971"]}, {"Citation": "Vlad R., Golu F., Toma A., Draganescu D., Oprea B., Chiper B. I. (2020). Depression and anxiety in Romanian medical students: Prevalence and associations with personality. Farmacia 68, 944\u2013949. 10.31925/farmacia.2020.5.24", "ArticleIdList": ["10.31925/farmacia.2020.5.24"]}, {"Citation": "Walsh C. A., Morrow E. M., Rubenstein J. L. (2008). Autism and brain development. Cell 135, 396\u2013400. 10.1016/j.cell.2008.10.015", "ArticleIdList": ["10.1016/j.cell.2008.10.015", "PMC2701104", "18984148"]}, {"Citation": "Wang J., Ferruzzi M. G., Ho L., Blount J., Janle E. M., Gong B., et al. (2012). Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J. Neurosci. 32, 5144\u20135150. 10.1523/JNEUROSCI.6437-11.2012", "ArticleIdList": ["10.1523/JNEUROSCI.6437-11.2012", "PMC3348654", "22496560"]}, {"Citation": "Wang R., Li Y.-B., Li Y.-H., Xu Y., Wu H.-L., Li X.-J. (2008). Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res. 1210, 84\u201391. 10.1016/j.brainres.2008.01.104", "ArticleIdList": ["10.1016/j.brainres.2008.01.104", "18420184"]}, {"Citation": "Wang R., Li Y.-H., Xu Y., Li Y.-B., Wu H.-L., Guo H., et al. (2010). Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 147\u2013153. 10.1016/j.pnpbp.2009.10.016", "ArticleIdList": ["10.1016/j.pnpbp.2009.10.016", "19879308"]}, {"Citation": "Wang R., Yan H., Tang X. C. (2006). Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin. 27, 1\u201326. 10.1111/j.1745-7254.2006.00255.x", "ArticleIdList": ["10.1111/j.1745-7254.2006.00255.x", "16364207"]}, {"Citation": "Wasilewska J., Klukowski M. (2015). Gastrointestinal symptoms and autism spectrum disorder: Links and risks\u2013a possible new overlap syndrome. Pediatr. Health Med. Ther. 6, 153\u2013166. 10.2147/PHMT.S85717", "ArticleIdList": ["10.2147/PHMT.S85717", "PMC5683266", "29388597"]}, {"Citation": "Wattanathorn J., Chonpathompikunlert P., Muchimapura S., Priprem A., Tankamnerdthai O. (2008). Piperine, the potential functional food for mood and cognitive disorders. Food Chem. Toxicol. 46, 3106\u20133110. 10.1016/j.fct.2008.06.014", "ArticleIdList": ["10.1016/j.fct.2008.06.014", "18639606"]}, {"Citation": "Weissman M. M., Olfson M. (1995). Depression in women: Implications for health care research. Science 269, 799\u2013801. 10.1126/science.7638596", "ArticleIdList": ["10.1126/science.7638596", "7638596"]}, {"Citation": "Wilens T. E., Spencer T. J. (2010). Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad. Med. 122, 97\u2013109. 10.3810/pgm.2010.09.2206", "ArticleIdList": ["10.3810/pgm.2010.09.2206", "PMC3724232", "20861593"]}, {"Citation": "Willcutt E. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics 9, 490\u2013499. 10.1007/s13311-012-0135-8", "ArticleIdList": ["10.1007/s13311-012-0135-8", "PMC3441936", "22976615"]}, {"Citation": "Willner P., Scheel-Kr\u00fcger J., Belzung C. (2013). The neurobiology of depression and antidepressant action. Neurosci. Biobehav. Rev. 37, 2331\u20132371. 10.1016/j.neubiorev.2012.12.007", "ArticleIdList": ["10.1016/j.neubiorev.2012.12.007", "23261405"]}, {"Citation": "Woo T. S., Yoon S. Y., Cheong J. H., Choi J. Y., Lee H. L., Choi Y. J., et al. (2011). Anticonvulsant effect of Artemisia capillaris Herba in mice. Biomol. Ther. Seoul. 19, 342\u2013347. 10.4062/biomolther.2011.19.3.342", "ArticleIdList": ["10.4062/biomolther.2011.19.3.342"]}, {"Citation": "Wood J. J., Drahota A., Sze K., Har K., Chiu A., Langer D. A. (2009). Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: A randomized, controlled trial. J. Child. Psychol. Psychiatry 50, 224\u2013234. 10.1111/j.1469-7610.2008.01948.x", "ArticleIdList": ["10.1111/j.1469-7610.2008.01948.x", "PMC4231198", "19309326"]}, {"Citation": "Woodward K. (2015). Psychosocial studies: An introduction. Routledge."}, {"Citation": "Wu E. Q., Shi L., Birnbaum H., Hudson T., Kessler R. (2006). Annual prevalence of diagnosed schizophrenia in the USA: A claims data analysis approach. Psychol. Med. 36, 1535\u20131540. 10.1017/S0033291706008191", "ArticleIdList": ["10.1017/S0033291706008191", "16907994"]}, {"Citation": "Wu J., Chen H., Li H., Tang Y., Yang L., Cao S., et al. (2016). Antidepressant potential of chlorogenic acid-enriched extract from Eucommia ulmoides Oliver bark with neuron protection and promotion of serotonin release through enhancing synapsin I expression. Molecules 21, 260. 10.3390/molecules21030260", "ArticleIdList": ["10.3390/molecules21030260", "PMC6274286", "26927040"]}, {"Citation": "Wulff K., Donato D., Lurie N. (2015). What is health resilience and how can we build it? Annu. Rev. Public Health 36, 361\u2013374. 10.1146/annurev-publhealth-031914-122829", "ArticleIdList": ["10.1146/annurev-publhealth-031914-122829", "25581148"]}, {"Citation": "Wynn J. K., Green M. F., Hellemann G., Karunaratne K., Davis M. C., Marder S. R. (2018). The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study. Schizophr. Res. 195, 572\u2013573. 10.1016/j.schres.2017.09.046", "ArticleIdList": ["10.1016/j.schres.2017.09.046", "28965778"]}, {"Citation": "Xu N., Li X., Zhong Y. (2015). Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators Inflamm. 2015, 531518. 10.1155/2015/531518", "ArticleIdList": ["10.1155/2015/531518", "PMC4333561", "25729218"]}, {"Citation": "Xu Y., Ku B.-S., Yao H.-Y., Lin Y.-H., Ma X., Zhang Y.-H., et al. (2005a). Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol. Biochem. Behav. 82, 200\u2013206. 10.1016/j.pbb.2005.08.009", "ArticleIdList": ["10.1016/j.pbb.2005.08.009", "16171853"]}, {"Citation": "Xu Y., Ku B.-S., Yao H.-Y., Lin Y.-H., Ma X., Zhang Y.-H., et al. (2005b). The effects of curcumin on depressive-like behaviors in mice. Eur. J. Pharmacol. 518, 40\u201346. 10.1016/j.ejphar.2005.06.002", "ArticleIdList": ["10.1016/j.ejphar.2005.06.002", "15987635"]}, {"Citation": "Xu Y., Ku B., Cui L., Li X., Barish P. A., Foster T. C., et al. (2007). Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res. 1162, 9\u201318. 10.1016/j.brainres.2007.05.071", "ArticleIdList": ["10.1016/j.brainres.2007.05.071", "17617388"]}, {"Citation": "Xu Y., Li S., Chen R., Li G., Barish P. A., You W., et al. (2010a). Antidepressant-like effect of low molecular proanthocyanidin in mice: Involvement of monoaminergic system. Pharmacol. Biochem. Behav. 94, 447\u2013453. 10.1016/j.pbb.2009.10.007", "ArticleIdList": ["10.1016/j.pbb.2009.10.007", "19857512"]}, {"Citation": "Xu Y., Wang Z., You W., Zhang X., Li S., Barish P. A., et al. (2010b). Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur. Neuropsychopharmacol. 20, 405\u2013413. 10.1016/j.euroneuro.2010.02.013", "ArticleIdList": ["10.1016/j.euroneuro.2010.02.013", "20353885"]}, {"Citation": "Y\u00e1\u00f1ez M., Fraiz N., Cano E., Orallo F. (2006). Inhibitory effects of cis-and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem. Biophys. Res. Commun. 344, 688\u2013695. 10.1016/j.bbrc.2006.03.190", "ArticleIdList": ["10.1016/j.bbrc.2006.03.190", "16631124"]}, {"Citation": "Yao X., Li L., Kandhare A. D., Mukherjee-Kandhare A. A., Bodhankar S. L. (2020). Attenuation of reserpine-induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol. Exp. Ther. Med. 19, 1343\u20131355. 10.3892/etm.2019.8328", "ArticleIdList": ["10.3892/etm.2019.8328", "PMC6966137", "32010308"]}, {"Citation": "Yeni Y., Cakir Z., Hacimuftuoglu A., Taghizadehghalehjoughi A., Okkay U., Genc S., et al. (2022). A selective histamine H4 receptor antagonist, JNJ7777120, role on glutamate transporter activity in chronic depression. J. Pers. Med. 12, 246. 10.3390/jpm12020246", "ArticleIdList": ["10.3390/jpm12020246", "PMC8880293", "35207733"]}, {"Citation": "Yi L.-T., Xu H.-L., Feng J., Zhan X., Zhou L.-P., Cui C.-C. (2011). Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiol. Behav. 102, 1\u20136. 10.1016/j.physbeh.2010.10.008", "ArticleIdList": ["10.1016/j.physbeh.2010.10.008", "20951716"]}, {"Citation": "Yoon S. Y., DELA Pe\u00f1a I. C., Shin C. Y., Son K. H., Lee Y. S., Ryu J. H., et al. (2011). Convulsion-related activities of Scutellaria flavones are related to the 5, 7-dihydroxyl structures. Eur. J. Pharmacol. 659, 155\u2013160. 10.1016/j.ejphar.2011.03.012", "ArticleIdList": ["10.1016/j.ejphar.2011.03.012", "21440538"]}, {"Citation": "Yoshino S., Hara A., Sakakibara H., Kawabata K., Tokumura A., Ishisaka A., et al. (2011). Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria. Nutrition 27, 847\u2013852. 10.1016/j.nut.2010.09.002", "ArticleIdList": ["10.1016/j.nut.2010.09.002", "21371861"]}, {"Citation": "Yu Y.-H., Xie W., Bao Y., Li H.-M., Hu S.-J., Xing J.-L. (2012). Saikosaponin a mediates the anticonvulsant properties in the HNC models of AE and SE by inhibiting NMDA receptor current and persistent sodium current. PLoS One 7, e50694. 10.1371/journal.pone.0050694", "ArticleIdList": ["10.1371/journal.pone.0050694", "PMC3510157", "23209812"]}, {"Citation": "Yudofsky S. C., Hales R. E. (2002). Neuropsychiatry and the future of psychiatry and neurology. Am. J. Psychiatry 159, 1261\u20131264. 10.1176/appi.ajp.159.8.1261", "ArticleIdList": ["10.1176/appi.ajp.159.8.1261", "12153815"]}, {"Citation": "Yusha'u Y., Muhammad U. A., Nze M., Egwuma J. M., Igomu O. J., Abdulkadir M. (2017). Modulatory Role of Rutin Supplement on Open Space Forced Swim Test Murine Model of Depression. Niger. J. Physiol. Sci. 32 (2), 201\u2013205.", "ArticleIdList": ["29485642"]}, {"Citation": "Zangara A. (2003). The psychopharmacology of huperzine A: An alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of alzheimer's disease. Pharmacol. Biochem. Behav. 75, 675\u2013686. 10.1016/s0091-3057(03)00111-4", "ArticleIdList": ["10.1016/s0091-3057(03)00111-4", "12895686"]}, {"Citation": "Zeni A. L. B., Zomkowski A. D. E., Maraschin M., Rodrigues A. L. S., Tasca C. I. (2012). Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: Evidence for the involvement of the serotonergic system. Eur. J. Pharmacol. 679, 68\u201374. 10.1016/j.ejphar.2011.12.041", "ArticleIdList": ["10.1016/j.ejphar.2011.12.041", "22266492"]}, {"Citation": "Zhang F., Lu Y.-F., Wu Q., Liu J., Shi J.-S. (2012). Resveratrol promotes neurotrophic factor release from astroglia. Exp. Biol. Med. 237, 943\u2013948. 10.1258/ebm.2012.012044", "ArticleIdList": ["10.1258/ebm.2012.012044", "22875340"]}, {"Citation": "Zhang L., Xu T., Wang S., Yu L., Liu D., Zhan R., et al. (2013). NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 12\u201317. 10.1016/j.pnpbp.2012.08.017", "ArticleIdList": ["10.1016/j.pnpbp.2012.08.017", "22960607"]}, {"Citation": "Zhang Z.-J. (2004). Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci. 75, 1659\u20131699. 10.1016/j.lfs.2004.04.014", "ArticleIdList": ["10.1016/j.lfs.2004.04.014", "15268969"]}, {"Citation": "Zhen L., Zhu J., Zhao X., Huang W., An Y., Li S., et al. (2012). The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system. Behav. Brain Res. 228, 359\u2013366. 10.1016/j.bbr.2011.12.017", "ArticleIdList": ["10.1016/j.bbr.2011.12.017", "22197297"]}, {"Citation": "Zheng L. T., Ock J., Kwon B.-M., Suk K. (2008). Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int. Immunopharmacol. 8, 484\u2013494. 10.1016/j.intimp.2007.12.012", "ArticleIdList": ["10.1016/j.intimp.2007.12.012", "18279803"]}, {"Citation": "Zhu H. L., Wan J. B., Wang Y. T., Li B. C., Xiang C., He J., et al. (2014). Medicinal compounds with antiepileptic/anticonvulsant activities. Epilepsia 55, 3\u201316. 10.1111/epi.12463", "ArticleIdList": ["10.1111/epi.12463", "24299155"]}, {"Citation": "Zuiki M., Chiyonobu T., Yoshida M., Maeda H., Yamashita S., Kidowaki S., et al. (2017). Luteolin attenuates interleukin-6-mediated astrogliosis in human iPSC-derived neural aggregates: A candidate preventive substance for maternal immune activation-induced abnormalities. Neurosci. Lett. 653, 296\u2013301. 10.1016/j.neulet.2017.06.004", "ArticleIdList": ["10.1016/j.neulet.2017.06.004", "28595950"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "22"}, {"Year": "2022", "Month": "8", "Day": "3"}, {"Year": "2022", "Month": "10", "Day": "3", "Hour": "5", "Minute": "10"}, {"Year": "2022", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "4", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["36188551", "PMC9521271", "10.3389/fphar.2022.926607", "926607"]}}], "PubmedBookArticle": []}